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ABSTRACT
Changes to the embryonic environment that occur within the first few days of
development can have significant effects on subsequent fetal development. The following
studies investigate the effects of progesterone-deprivation during the early
preimplantation period in the mare. The first study described embryo morphology
(diameter, stage, and quality grade) collected from mares with induced aluteal cycles.
The second study evaluated the effect of induced aluteal cycles on the future fertility of
embryo collections as a potential method for cycle manipulation of embryo donor mares.
The third study characterized embryonic and endometrial transcript expression of
progesterone-mediated transcripts as well as those related to normal embryo growth and
pregnancy establishment during induced aluteal cycles. Finally, the fourth study
evaluated the potential for the successful establishment of pregnancy when
preimplantation embryos were deprived of progesterone. Embryos developed in a
progesterone-deprived environment were developmentally delayed by all parameters
evaluated. A significant effect was seen on the transcript expression of embryos and
endometrium collected from progesterone-deprived cycles in the mare. Embryos deprived
of progesterone during the early preimplantation period demonstrated delayed embryonic
vesicle growth compared to control cycles. No effect was seen on the future fertility of
embryo collections after utilizing progesterone-deprived cycles. The results of these
studies elucidate the significance of adequate progesterone levels beginning immediately
post-ovulation in the mare.
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CHAPTER 1: GENERAL INTRODUCTION
1.1 General Introduction
The corpus luteum (CL) is a temporary endocrine structure formed on the ovary
[1.1]. This structure plays an integral role in the establishment and maintenance of
mammalian pregnancy. In the mare, this structure is the primary source of progesterone
during the first one third of gestation and progesterone is detectable at high
concentrations in maternal plasma (>10 ng/mL) [1.2, 1.3]. Progesterone plays a role in
regulating uterine quiescence and nourishes the embryo prior to implantation by the
production of histotroph [1.4, 1.5]. Adequate progesterone levels are required to maintain
pregnancy and embryonic loss in the mare has been associated with plasma progesterone
levels < 2 ng/mL [1.6]. The equine pregnancy is unique among mammals with an
extended period of preimplantation embryo development prior to attachment and
placentation [1.7]. Recent studies have investigated the effects of periovulatory doses of
prostaglandin F2α (PGF2α) on luteal function, embryo development and pregnancy in
mares [1.7-1.13].
1.2 Corpus Luteum
The preovulatory follicle undergoes many changes prior to ovulation in
preparation for luteogenesis. During late estrus and prior to ovulation, the preovulatory
follicle becomes less responsive to gonadotropins [1.14]. This results in a shift of steroid
hormone secretion from estradiol to progesterone within the follicle [1.14]. After
ovulation of the dominant follicle, the CL forms as a transient endocrine gland that
maintains the luteal phase of the estrous cycle [1.1]. The rapid proliferation of capillaries
that occurs during the early stage of CL development has been compared to the
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vascularization of solid tumors [1.15]. At the time of ovulation, intense changes occur in
the endothelium of vessels surrounding the follicle [1.15]. Within 48 hours a new
complex network of vessels has developed and invaded the previously avascular
granulosa cell layers, which induces luteinization and later nourishes the CL [1.15].
Several factors have been implicated in the regulation of CL angiogenesis including
vascular endothelial growth factor, cytokines, tumor necrosis factor α, and interferon
gamma [1.1, 1.16].
The CL forms on the ovary after ovulation. In most mammals the follicular theca
and granulosa cells begin a rapid turnover to form the small and large luteal cells
respectively [1.17]. The resulting large luteal cells are relatively unresponsive to LH and
secrete high basal quantities of progesterone whereas small luteal cells secrete low basal
quantities of progesterone and are responsive to LH [1.18, 1.19]. The histology of the
equine CL differs as only the granulosa cells of the preovulatory follicle contribute to the
fully formed equine CL [1.20]. In contrast to other species, the theca interna cells
degenerate at ovulation in the mare and the cause for cell degeneration remains to be
elucidated (apoptosis vs. necrosis) [1.20, 1.21].
In the absence of pregnancy, luteolysis occurs naturally at the end of diestrus to
allow a return to estrus and chance for rebreeding. The luteolytic process requires
multiple triggering factors working synergistically which include PGF2α, nitric oxide,
and cytokines [1.22-1.25]. As a result, the CL undergoes both functional and structural
regression; resulting in a reduction in progesterone production and changes in luteal
tissue morphology. It has been demonstrated that apoptosis in the CL is essential in
regulating cell number and is mediated by nitric oxide as well as cytokine receptors such
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as Fas ligand [1.22]. A decrease in progesterone production has been described as a direct
negative effect of PGF2α [1.26]. The endogenous luteolysin, PGF2α, is released from the
endometrium in a pulsatile manner [1.27-1.29]. Furthermore, the secretion of PGF2α is
stimulated by the pulsatile release of oxytocin, which is affected by the concentration of
endometrial oxytocin receptors [1.30]. Endometrial oxytocin receptor concentration has
been demonstrated to be lowest during estrus and highest on Day 14 in non-pregnant
mares [1.30]. Additionally, oxytocin receptor affinity is lower in pregnant than nonpregnant mares [1.30].
The CL is a key component of diestrus and manipulation of the equine estrous
cycle often centers on the presence or absence of a CL. Hormonal manipulation focuses
on either the termination of or prolonging the lifespan of the CL. Exogenous
progestagens have been administered to mimic the presence of a CL in an attempt to
synchronize ovulation of a group of mares [1.31]. The success of this technique varies
greatly according to the stage of the cycle and average follicle size when treatment is
administered [1.32]. Conversely, termination of a CL is achieved by administration of
exogenous PGF2α with reports of its use inducing luteolysis as early as the 1970s [1.33,
1.34].
1.3 Prostaglandin F2 Alpha
There are a several aspects of the reproductive physiology and endocrinology of
the mare that makes them unique among large animals, one of which is the relationship
between luteal blood flow and luteolysis [1.35]. Horses lack countercurrent exchange
between the uterine vein and the ovarian artery compared to ruminants [1.36]. As a result
of this unique anatomy, PGF2α must travel systemically from the uterus to the ovary in
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mares vs. local action in ruminants where the uterine vein is closely associated with the
ovarian artery [1.36]. Additionally, the plasma clearance of PGF2α is five times slower in
mares compared to heifers, resulting in a longer half-life [1.37]. It has been described that
the equine is approximately 18 times more sensitive to the luteolytic effects of systemic
administration of PGF2α than the bovine CL [1.36, 1.38]. An in vitro study demonstrated
that equine luteal cell membrane preparations had an affinity for PGF2α 10 times greater
than bovine luteal cell preparations [1.39]. A combination of these factors; the high
affinity of the mare CL to binding of PGF2α and the relatively slow metabolic clearance,
account for the greater sensitivity of the mare CL compared to other domestic species
[1.40].
The administration of PGF2α and its analogues have been utilized to induce
luteolysis in mares for over 5 decades. For almost as long, it was believed that the CL
was refractory to exogenous administration of PGF2α and luteolysis could not be induced
prior to Day 5 [1.41]. Only recently have studies challenged this dogma. In the last two
decades multiple studies have investigated the effects of periovulatory doses of PGF2α
on luteal function and pregnancy rates in mares [1.7-1.12, 1.42, 1.43]. Several studies
with varying single daily doses of PGF2α (cloprostenol) administered on Days 0, 1, and 2
post-ovulation had a transient effect on plasma progesterone concentrations [1.7, 1.11,
1.12]. In mares treated with 3 periovulatory doses of PGF2α, a decrease in plasma
progesterone concentrations was observed, but levels rose to > 2.0 ng/mL by Days 4 and
5 in those studies [1.7, 1.11, 1.12]. Interestingly, a model has been developed which
reliably prevents normal luteal function in all treated mares administered serial doses of
PGF2α beginning within 12 hours of ovulation [1.8, 1.10]. This model demonstrates that
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the early equine CL is responsive to PGF2α and normal luteal function can be completely
interrupted if serial doses are administered during the early postovulatory period [1.8,
1.10].
1.4 Progesterone
Progesterone has long been considered the hormone essential for conception and
establishment of pregnancy in mammalian reproduction. It has been demonstrated that in
horses the CL is the exclusive source of progesterone during the first 150 days of
gestation [1.3]. Sufficient progesterone concentrations are essential for maintaining
pregnancy during the early postovulatory period between Days 2 to 5 [1.7]. High
embryonic death occurs in the equine and it has been estimated that 30-40% of
pregnancies are lost during the first 2 weeks following high fertilization rates [1.44]. The
cause of early embryonic death is often unknown but has been attributed to
hypoluteoidism [1.3, 1.45]. It has been described that increased embryo survival is more
likely to occur when circulating progesterone concentrations are > 4 ng/mL compared to
decreased survival when < 2 ng/mL [1.6].
Progesterone maintains uterine quiescence by reducing the number of gap
junctions for uterotonic hormones, such as prostaglandin F2α and oxytocin on the
myometrium [1.46, 1.47]. The endometrium is primed by progesterone to produce the
uterine histotroph, which is essential to conceptus survival and growth [1.48]. The
histotroph contains a multitude of proteins that are essential for the survival, growth and
development of the preimplantation embryo [1.49]. It has been demonstrated in sheep
that the endometrial gland density is directly related to the survival and development of
the conceptus [1.50]. Additionally, studies utilizing an ovine uterine gland knockout
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model have demonstrated that functional endometrial glands and their secretions are
necessary to ensure conceptus elongation and survival [1.51].
1.5 The Early Preimplantation Period
During the early preimplantation period there are again differences present in the
equine compared to that of other domestic species. Implantation in the horse is protracted
compared to other domestic animals; an extended period of conceptus development
precedes implantation and placentation [1.51]. Due to the prolonged preimplantation
period in the mare, adequate histotroph is especially important to nurture the embryo and
maintain pregnancy [1.52]. The conceptus-initiated signal for maternal recognition of
pregnancy (MRP) has yet to be elucidated in the mare compared to other domestic
species. Certain factors have been found to be essential so the MRP signal can be
released such the equine conceptus mobility throughout the uterus between Day 7 and 17
[1.53]. Additionally, an immunosuppressive protein called “early pregnancy factor,” an
extracellular form of heat shock protein 10, has been described in the mare [1.54, 1.55].
These factors ensure that MRP can properly occur to ensure continuation and secretory
function of the CL beyond its normal lifespan [1.53]. This maintains the uterus in the
appropriate progestational progesterone rich environment to support the developing
pregnancy [1.53].
The equine embryo enters the uterus on Day 6, typically a morula at
approximately 150 μm in diameter [1.56]. Between Day 6 to Day 8 the equine embryo
rapidly grows and develops into a blastocyst then expands [1.57]. The embryo begins to
form the capsule between the trophoblast and the inner surface of the zona pellucida
[1.57]. Shortly after capsule formation is complete, the zona pellucida is shed from the
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equine embryo [1.57]. The capsule is a structurally strong, acellular mucin-like
glycoprotein matrix essential to pregnancy and protection of the embryo [1.58]. The
lipocalin P19 produced by the equine endometrium is essential to the development of the
capsule as it has been demonstrated that embryos developed in vitro do not develop a
complete and cohesive capsule or shed their zona pellucida [1.59, 1.60]. Furthermore, it
has been elucidated that P19 is mediated by progesterone and is one of the most abundant
proteins found in the equine uterine histotroph [1.59].
1.6 Scope of the Dissertation
It has been described that progesterone production as early as Day 2 postovulation can have a significant effect on pregnancy outcome in the mare [1.7].
Furthermore, hypoluteoidism has been implicated as a factor of EED in the mare [1.3,
1.45]. The occurrence of EED each breeding season results in significant economic loss
to the equine industry. The aim of the dissertation was to investigate the effects of
progesterone-deprivation on the equine embryo and endometrium during the early
preimplantation period in the mare. These studies may further elucidate the effects of
hypoluteoidism on EED in the mare. The following series of studies utilized a novel in
vivo model developed in our laboratory to prevent the formation of a functional CL
immediately post-ovulation by administering serial doses of PGF2α beginning within 12
hours post-ovulation [1.8, 1.10]. Mares treated according to this protocol consistently
have mean concentrations of plasma progesterone < 1.0 ng/mL (induced aluteal cycles)
throughout the study period [1.8, 1.10].
The objective of the first study was to describe the morphology of embryos
(diameter, stage, and quality grade) collected from mares with induced aluteal cycles.
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The second study sought to characterize embryonic and endometrial expression of
progesterone-mediated transcripts as well as those related to normal embryo growth,
pregnancy establishment, and prostaglandin synthesis during induced aluteal cycles. The
objective of the third study was to evaluate the difference in early pregnancy
development when preimplantation embryos were deprived of progesterone. Finally, the
fourth study sought to evaluate the effect of induced aluteal cycles on the future fertility
of embryo collections as a potential method for cycle manipulation of embryo donor
mares. The results of these studies are described in detail in the following chapters.
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CHAPTER 2: MORPHOLOGICAL EVALUATION OF DAY 8 EMBRYOS
DEVELOPED DURING INDUCED ALUTEAL CYCLES IN THE MARE1
2.1 Summary
A novel in vivo model utilizing serial administrations of PGF2α to induce aluteal
cycles in the mare was used to evaluate the effects of progesterone-deprivation on the
morphology of in vivo preimplantation embryos. We hypothesized that equine embryos
produced during induced aluteal cycles (AL) would be developmentally affected,
characterized by earlier embryo stage at collection, smaller embryo diameter, and lower
quality grade, compared with those collected on the same day post-ovulation from control
cycles during diestrus (high progesterone; > 4 ng/mL). Seven cyclic mares with a median
age of 6.5 years (range 3-16) were utilized in a crossover design. Mares in estrus were
artificially inseminated to a fertile stallion and randomly assigned to control or AL
groups. Mares received either saline solution (control mares) or PGF2α (AL mares),
twice daily on days 0, 1, and 2 and once daily on days 3 and 4. Serial blood samples were
collected daily during estrus and until the day of embryo collection 8 days after
ovulation. Mares were monitored until they returned to estrus, and artificially
inseminated. Mares were switched to the opposite treatment group only after a successful
embryo collection occurred during the previous cycle. Only cycles that produced
embryos were used for analyses. No significant rise in progesterone was observed in the
AL group with mean concentrations of plasma progesterone remaining < 1.0 ng/mL from
ovulation until embryo collection on Day 8. This is in sharp contrast to the control

This chapter previously appeared as Leisinger CA, Medina V, Markle ML, Paccamonti
DL, Pinto CRF. Morphological evaluation of Day 8 embryos developed during induced
aluteal cycles in the mare. Theriogenology 2018;105:178-83.
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(luteal) cycle where a post-ovulatory rise in plasma progesterone was observed. The
mean daily concentrations of plasma progesterone were significantly higher in control vs.
AL group beginning at Day 3 and remained so until Day 8. The mean (±SEM) embryo
diameter of AL embryos was 171 ± 5 μm compared to 756 ± 99 μm for control embryos.
The majority of the Day 8 AL embryos were classified as morulae (3/9) or early
blastocysts (5/9) with only 2 embryos of quality grade 1 compared to the Day 8 control
embryos that were mostly expanded blastocysts (6/7) with 5 of 6 being of quality grade 1.
This study shows that serial administrations of PGF2α were able to prevent significant
rises in plasma progesterone, thus inducing aluteal cycles characterized by a
progesterone-deprived environment for developing embryos. Embryos collected from
induced aluteal cycles were adversely affected as demonstrated by a lower quality grade,
smaller diameter and earlier embryo stage at collection when compared to control
embryos.
2.2 Introduction
There is strong evidence to support a crucial role for progesterone in regulating
early pregnancy events in the horse, including preimplantation embryo development and
embryo-maternal signaling for pregnancy. The correct maternal-embryo crosstalk during
the preimplantation period is essential to establish pregnancy, specifically by ensuring
corpus luteum maintenance and progesterone secretion [2.1]. Throughout the first 150
days of pregnancy in the mare, progesterone is detectable at high concentrations in the
maternal plasma (> 10 ng/mL) and is produced by the primary and secondary corpora
lutea (CL) of the ovary [2.2]. During the first 40 days of gestation in the mare, the
primary CL is the sole source of progesterone [2.3]. One of the primary determinants of
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an adequate environment conducive to the establishment of pregnancy is the continued
supply of ovarian progesterone from the CL [2.1]. Progesterone is essential to provide the
appropriate intrauterine environment for conceptus development [2.4]. Progesterone
induces the production of endometrial histotroph, which is the primary conceptus
nutrition until placentation [2.5]. The requirement for progesterone to drive uterine
secretions necessary for conceptus development has been demonstrated in a variety of
ways. For example, ovariectomized mares established and maintained pregnancy when
administered only exogenous progesterone prior to the embryo transfer and during the
first 100 days of gestation [2.6].
In addition to the production of endometrial histotroph, progesterone plays a role
in the establishment and maintenance of early pregnancy by ensuring myometrial
quiescence [2.7]. It reduces uterine contractility and the number of gap junctions and
receptors for uterotonic hormones, such as prostaglandin F2α and oxytocin on the
myometrium [2.8, 2.9]. These are key functions for the initiation of maternal recognition
of pregnancy (MRP) events in the mare. The events of MRP describe embryo-maternal
communication during early pregnancy that prevents luteolysis to ensure ongoing
progestational support that is vital for embryo development [2.10]. If proper MRP does
not occur, early embryonic death (EED) may result. High embryonic death and
significant economic loss occurs during early pregnancy in the equine. It is estimated that
30-40% of pregnancies are lost within 2 weeks following high fertilization rates [2.11].
The cause of EED remains largely unknown during the early period and has been
attributed to a variety of factors. One of these factors may be hypoluteoidism, which is a
condition characterized by low levels of progesterone incompatible to support early
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pregnancy in the mare [2.3, 2.12]. It has been described that embryonic loss is more
likely to occur when the circulating progesterone concentration is < 2 ng/mL compared to
increased embryonic survival associated with progesterone concentrations > 4 ng/mL
[2.13].
For the present study, we developed a novel model to induce aluteal cycles,
characterized by a progesterone-deprived environment following ovulation.
Administrations of serial doses of PGF2α beginning during the early post-ovulatory
period have been shown to alter luteal development and function as evidenced by
changes in concentrations of plasma progesterone [2.14-2.22]. Based on these effects, a
series of studies in our laboratory refined a model to prevent the formation of a functional
corpus luteum immediately post-ovulation (antiluteogenesis) [2.14]. In this model serial
administration of PGF2α beginning within 12 hours post-ovulation (Day 0) was
administered twice daily on Days 0, 1, and 2 and then once daily on Days 3 and 4 [2.14].
Mares treated according to this protocol consistently had mean concentrations of plasma
progesterone < 1.0 ng/mL throughout (and after) the study period Days 0–5 postovulation [2.14]. In a subsequent proof of concept study, we have also reported that
embryonic development could occur in mares that were artificially inseminated and
underwent antiluteogenic treatment (serial administration of PGF2α) after ovulation
[2.19]. Furthermore, embryos developing in this low progesterone environment could be
“rescued” by the administration of exogenous progestin [2.19]. Therefore, this study was
designed to evaluate the effects of progesterone-deprivation on in vivo embryos collected
from progesterone-deprived cycles in the mare during the early preimplantation period,
specifically days 0–8 post-ovulation. The objective of this study was to describe the
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morphology of embryos (diameter, stage, and quality grade) collected from mares with
induced aluteal cycles. We hypothesized that equine embryos produced during induced
aluteal cycles (progesterone-deprived environment; < 1.0 ng/mL) would be
developmentally affected, characterized by earlier embryo stage at collection, smaller
embryo diameter, and lower quality grade, compared with those collected on the same
day post-ovulation from control cycles during normal diestrus.
2.3 Materials and Methods
The Institutional Animal Care and Use Committee of Louisiana State University
School of Veterinary Medicine approved all experimental protocols. The work was
performed in a USDA-registered National Institute of Health-assured, and AAALAC
International accredited animal facility in accordance with The Guide for the Care and
Use of Laboratory Animals [2.23]. Seven cyclic Thoroughbred mares with a median age
of 6.5 years (range 3-16) were utilized in a balanced crossover design from March to
September 2016 in Baton Rouge, LA. Mares were randomly assigned to one of two
treatment groups: control (normal diestrus) or induced aluteal (AL). Mares remained in
the first assigned treatment group until a successful embryo collection. Immediately after
the first successful embryo collection, they were assigned to the opposite treatment group
and remained in that treatment group until a successful embryo collection. This study
design resulted in the production of paired embryos from control and AL cycles from the
same mare for analyses.
Mares were monitored by transrectal ultrasonography (SonoSite Edge, Fujifilm,
Bothell, WA) throughout the study period. Mares in estrus as determined by the presence
of uterine edema and with a follicle > 35 mm diameter were treated once with 2000 IU of
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human chorionic gonadotropin (hCG) administered intravenously (Chorulon, Merck
Animal Health, Kenilworth, NJ). Mares were artificially inseminated every other day
until ovulation was detected with ≥ 1 x 109 total motile spermatozoa from one stallion of
known fertility. Reproductive examinations by ultrasonography were performed twice
daily after insemination until detection of ovulation. After ovulation, mares were
randomly assigned to one of two treatment groups: control (normal diestrus) or induced
aluteal (AL). The AL mares were treated according to a protocol previously described
[2.14]. Briefly, mares were treated twice daily with PGF2α (10 mg, IM, Lutalyse,
dinoprost tromethamine, Zoetis, Florham Park, NJ) on days 0, 1, and 2, and once daily on
days 3 and 4 [2.14]. The control group was treated on the same schedule with saline
solution (2 mL, IM). Embryo collections were performed on Day 8 post-ovulation.
Embryos were collected in an aseptic manner using Lactated Ringers Solution (LRS)
with no supplementation (MWI Veterinary Supply, Boise, ID). The uterus was lavaged
with 0.5 to 1 L of LRS at a time and an average 4 to 6 L of LRS was used in total.
Recovered embryos were classified using a stereomicroscope (SMZ800, Nikon, Melville,
NY) according to stage of development and assigned a quality grade on a scale of 1-4
[2.24]. Briefly, quality grade 1 was assigned to embryos with no abnormalities, spherical
shape, uniform size, color and texture; grade 2 embryos had minor imperfections
demonstrated by some extruded blastomeres, and slight irregularities in shape, size, color
or texture; grade 3 embryos had moderate imperfections demonstrated by large
percentage of extruded blastomeres, partial collapse of blastocele, or moderate shrinkage
of trophoblast from zona pellucida; grade 4 embryos had complete degeneration and
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embryonic death [24]. Additionally, embryos were photographed and their diameter
measured (Nikon DSI-Fi2 camera with DS-L3 camera control, Nikon, Melville, NY).
Mares were monitored for a return to estrus by ultrasonography every other day
after embryo collection. Once in estrus, mares were artificially inseminated and managed
as described above. Mares remained in the same treatment group until an embryo was
successfully collected. After a successful embryo collection, mares were assigned to the
opposite treatment group. Only control or AL cycles with a successful embryo collection
were used for statistical analyses.
Serial blood samples were collected from the time mares ovulated (Day 0) until
embryo collection 8 days post-ovulation in both control and AL groups. Plasma was
harvested and stored at -20° C until assayed for progesterone. Concentrations of plasma
progesterone were determined by a progesterone radioimmunoassay (RIA). For the
progesterone RIA, both the intraassay and interassay coefficients of variants were < 15%.
A technician blinded to treatment protocols and groups performed the progesterone
assays using a MP Biomedical double antibody approach as previously described [2.25].
Statistical significance for all data analyses was set at P ≤ 0.05. Data for embryo
diameter was analyzed using a one-tailed paired t-test and data for stage of embryo
development and quality grade were analyzed using a one-tailed Wilcoxon signed-rank
test. Concentrations of plasma progesterone were analyzed by ANOVA for repeated
measures. All statistical analyses were carried out using Sigma Plot V12.5 (Systat
Software, San Jose, CA). Data are expressed as mean ± SEM.
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2.4 Results
A total of 7 successful embryo collections were recorded in both the control group
and the AL group. A total of 7 embryos were collected from control embryo collections
and a total of 9 embryos were collected from AL embryo collections as two mares had
double ovulations in the AL cycles (Table 2.1). Overall the stage of embryo collected
from control vs. AL cycles differed significantly (p < 0.01). In the control cycles, 86%
(6/7) of embryos collected on Day 8 were classified as expanded blastocysts and 14%
(1/7) were classified as blastocysts (Table 2.1, Fig. 2.1). In contrast, embryos collected
from AL cycles on Day 8 were 33% (3/9) morulae, 56% (5/9) early blastocysts and 11%
(1/9) blastocysts (Table 2.1, Fig. 2.1). Furthermore, the mean embryo diameter differed
significantly in control vs. AL groups, 756 ± 99 μm vs. 171 ± 5 μm, respectively (p <
0.001) (Table 2.1, Fig. 2.1). Additionally, the quality grades of AL embryos (2 ± 0.26)
was significantly lower than that of control embryos (1 ± 0.18), (p < 0.05) (Table 2.1).
No rise in plasma progesterone was observed in the AL group with mean
concentrations remaining < 1.0 ng/mL from Day 0 until embryo collection on Day 8 (Fig.
2.2). This is in contrast to the control (luteal) group where a post-ovulatory rise in
progesterone was documented (Fig. 2.2). The mean concentration of progesterone in the
control group rose to 2.8 ng/mL on Day 2, in contrast to a mean concentration of
progesterone of 0.7 ng/mL in the AL group (Fig. 2.2). The mean daily concentration of
progesterone of mares in the AL group remained < 1.0 ng/mL throughout the duration of
the study (Fig. 2). The mean daily concentrations of progesterone differed significantly
between control vs. AL group beginning on Day 3 and remained so through Day 8 (p <
0.001) (Fig. 2).
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Table 2.1 Developmental stage, quality grade, and diameter of embryos recovered Day 8
post-ovulation from control and induced aluteal cycles in each of the seven mares
enrolled in the study.
MARE
ID

CONTROL CYCLE
EMBRYO QUALITY
STAGE
GRADE*

DIAMETER
(μm)

1

Blastocyst 1

360

2
3

4
5
6
7

Expanded
blastocyst
Expanded
blastocyst
Expanded
blastocyst
Expanded
blastocyst
Expanded
blastocyst
Expanded
blastocyst

1

1122

1

663

ALUTEAL CYCLE
EMBRYO QUALITY
STAGE
GRADE*

DIAMETER
(μm)

Early
2
blastocyst
Early
2
blastocyst
Blastocyst 1

180

2

188

2

175

3

151

175
195

2

600

Early
blastocyst
Early
blastocyst
Morula

1

884

Morula

1

151

2

660

3

161

1

1006

Early
blastocyst
Morula

3

178

2.5 Discussion
The present study utilized a novel in vivo model to evaluate the effects of lack of
progesterone on early embryo development in the mare. Progesterone-deprived (aluteal)
cycles defined by mean plasma progesterone < 1.0 ng/mL were induced in all mares
subjected to serial PGF2α treatments in the AL group. The serial administration of
PGF2α beginning within 12 hours of ovulation had a significant effect on the developing
corpus luteum prior to Day 3 post-ovulation. The absence of a significant rise in
progesterone after ovulation in mares in the AL group indicated that early luteal cells are
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(a1)

(a2)

(b1)

(b2)

Fig. 2.1. Two pairs of embryos collected 8 days post-ovulation from control and induced
aluteal cycles of two different mares. These embryo pairs illustrate the profound effect of
progesterone-deprivation on embryo stage and diameter. Pairs of the same letter indicate
the embryo was collected from control and induced aluteal cyles in the same mare. a1)
An expanded blastocyst measuring 884 μm in diameter from a control cycle. a2) A
morula measuring 151 μm in diameter from an induced aluteal cycle. b1) An expanded
blastocyst measuring 1031 μm in diameter from a control cycle. b2) A morula measuring
178 μm in diameter from an induced aluteal cycle.
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Fig. 2.2 Mean (± S.E.M.) daily concentrations of plasma progesterone in control and
induced aluteal treatment groups. During the induced aluteal treatment, note that serial
administration of PGF2α immediately post-ovulation twice daily on Days 0, 1, and 2,
then once daily on Days 3 and 4 caused the mean daily concentrations of plasma
progesterone to remain below 1.0 ng/mL. This is in contrast to the control (luteal) cycle
where a post-ovulatory rise in progesterone was observed. The mean daily concentrations
of plasma progesterone differed significantly in control vs. aluteal group beginning at
Day 3 until Day 8 (*; p < 0.001)
being affected by PGF2α much earlier than previously thought. The plasma concentrations
of progesterone of aluteal cycles contrasted greatly to that of control cycles resulting in a
clearly defined progesterone-deprived environment following ovulation in the mare.
Additionally, the embryo quality and stage of development were adversely affected in
Day 8 embryos collected from AL cycles when compared with Day 8 embryos collected
from control cycles.
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To our knowledge this is the first study describing in vivo embryo development in
a progesterone-deprived environment from Day 0 to Day 8 followed by embryo
collection and evaluation. The present study utilized a previously validated model
administering serial PGF2α treatments beginning within 12 hours of ovulation to reliably
prevent normal luteal function (antiluteogenesis) in the mare [2.14]. Several studies have
been conducted evaluating the effects of periovulatory doses of PGF2α on early luteal
function and pregnancy rates in the mare [2.20-2.22]. These studies resulted in a transient
interruption of early CL development when varying single daily doses of PGF2α
(cloprostenol) were administered on Days 0, 1, and 2 post-ovulation as an approach to
treat delayed uterine clearance in mares following breeding [2.20-2.22]. In those studies,
concentrations of plasma progesterone did remain low for several days following
ovulation in mares treated with three periovulatory doses of PGF2α administered once
daily [2.20-2.22]. By days 4 and 5 after ovulation mares in those studies experienced
resurgence in luteal function as concentrations of plasma progesterone rose above 2.0
ng/mL [2.20-2.22]. These results are in sharp contrast to the present study where serial
administration of eight doses of PGF2α beginning within 12 hours of ovulation (Day 0)
and continuing until Day 4 completely prevented the formation of a functional CL in all
treated mares. As a result, aluteal cycles, as defined by mean plasma progesterone < 1.0
ng/mL, were induced in all mares throughout the study period when subjected to serial
PGF2α treatments in the AL group.
In this study, the concentrations of plasma progesterone were significantly altered
in the AL group where mean concentrations remained < 1.0 ng/mL from ovulation (Day
0) until embryo collection (Day 8). This contrasted drastically to the control group where
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mean concentrations of plasma progesterone were > 2.0 ng/mL beginning on Day 2 and a
typical diestrus rise was observed throughout the study period. Sufficient progesterone
concentrations are crucial for maintaining pregnancy during the early stages of CL
development [2.22]. The uterine histotroph is thought to be especially important for
conceptus survival and development in sheep, cattle, pigs, and especially in horses, in
which an extended period of preimplantation conceptus development precedes
attachment and placentation [2.26]. Studies utilizing ovine uterine gland knockout model
ewes have shown the importance of functional endometrial glands and their secretions to
preimplantation conceptus development and survival [2.26]. Numerous proteins secreted
by the equine endometrium and vital to the development of the conceptus are
progesterone dependent. One of the most abundant proteins of the equine uterine
histotroph is P19, a lipocalin important in the assembly of the embryonic capsule [2.27].
Due to the administration of multiple doses of PGF2α beginning immediately post
ovulation, we were able to completely prevent normal luteal formation (antiluteogenesis)
as demonstrated by mean concentrations of plasma progesterone remaining < 1.0 ng/mL
in all PGF2α-treated mares. The resulting progesterone-deprivation for the duration of the
study likely had unfavorable effects on the development of uterine histotroph.
It has been demonstrated in several species that progesterone plays a key role in
regulating gamete transport through the uterine tube. One aspect that makes the equine
embryo unique is the prolonged transport through the oviduct lasting 6 days [2.28]
Progesterone has been shown to play a crucial role in regulating ciliary beat frequency in
vitro in the mouse, cow and human and in vivo in the guinea pig [2.29-2.32]. Regulation
of ciliary motility is essential to facilitate the meeting of gametes and subsequent
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transport of tubal stage embryos [2.29]. Additionally, the binding of progesterone
receptor β in human oviductal epithelium affects smooth muscle relaxation, which is an
important mechanism of oocyte transport from the ampulla to isthmus portion of the tube
[2.30]. A progesterone-deprived environment may alter the day the embryo enters the
uterus due to delayed transport through the uterine tube resulting in an altered embryomaternal interaction.
When equine embryos enter the uterus they are typically a late morula measuring
approximately 150 μm in diameter [2.33]. They rapidly develop from a morula to an
expanded blastocyst one to two days after entering the uterus. A normal Day 8 equine
embryo should be an expanded blastocyst, visible to the naked eye with a diameter of
500-1000 μm [2.33]. The Day 8 embryos collected in the control group displayed the
expected characteristics of normal embryos. All of the control embryos collected except
one were classified as expanded blastocysts and were between 600-1122 μm in diameter.
This is in sharp contrast to the Day 8 AL embryos that were much earlier in development
with approximately half of the embryos classified as early blastocyst and one third
classified as morula with diameters between 151-195 μm. Furthermore, the quality of the
AL embryos was significantly lower than the control embryos, indicating a negative
effect of progesterone-deprivation on normal embryonic development.
In the equine embryo, coalescence of the endoderm colonies on the inside of the
trophoblast at Day 8 completes yolk sac formation, which in turn initiates functional
changes in the conceptus [2.34]. It has been described that the equine conceptus initiates
steroidogenesis as early as Day 6 based on histochemical evidence of 3β-HSD [2.35].
However, stain intensities of 3β-HSD in Day 6 and 7 blastocysts are weaker with
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measureable amounts of progesterone, androgens, and estrogens isolated from Day 8
blastocyst in the horse [2.35]. Once the yolk sac has completely formed, it secretes
growth hormones, expresses proteins, and synthesizes and metabolizes steroids [2.34]. By
Day 12 the equine conceptus produces significant quantities of estrogens and this activity
continues to increase until Day 20 [2.35, 2.36]. It is likely that conceptus-derived
estrogens, acting via endometrial estrogen receptors, do influence uterine function in a
way that remains to be elucidated [2.37]. Interestingly, conceptus estrogens do not appear
to regulate luteal maintenance in mares [2.38]. Additionally, it has been described that the
Day 7 equine conceptus expresses mRNA for both intracellular progesterone receptors
and membrane bound progesterone receptors [2.39]. It has been hypothesized that the
reproductive steroids may exert their effects on the preimplantation equine conceptus
directly, and not only via the endometrium [2.39]. The purpose of this study was to
evaluate Day 8 embryos developed in a progesterone-deprived environment. Embryos
collected in this study were collected on Day 8, the day of yolk sac completion and prior
to the synthesis of significant levels of estrogens. Without a properly progesterone
primed uterus secreting histotroph to provide adequate nutrients for the conceptus to
develop and begin to secrete its own proteins and steroids, the events of MRP will likely
be impaired [2.40]. Therefore, this model provides insight into the detrimental effects of
hypoluteoidism on the endometrium and conceptus during the pre-implantation and MRP
period in the horse. This novel in vivo model inducing progesterone deprivation during
diestrus in the mare may offer the ability to further evaluate the direct effects of
progesterone on the preimplantation equine conceptus and subsequent MRP events.
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2.6 Conclusions
There is strong evidence to support a crucial role for progesterone in regulating
early pregnancy events in the horse, including embryo development. The role of
progesterone in the establishment of pregnancy in the mare is well described, but the
specifics effects of progesterone deprivation on preimplantation embryo development
have not been investigated. In this study, we highlight a novel in vivo approach to
produce embryos in a progesterone-deprived environment (AL cycles) induced by serial
administration of PGF2α at ovulation. In all AL cycles the mean concentrations of plasma
progesterone were < 1.0 ng/mL from ovulation (Day 0) until embryo collection (Day 8).
The embryo quality was adversely affected and stage of development was retarded during
the AL cycles. The production of aluteal embryos may serve as a novel in vivo model to
investigate the direct and lasting effects of progesterone on preimplantation equine
conceptuses. Further investigation applying this model can be utilized to investigate
embryo-maternal interactions in the mare, especially those mediated directly or indirectly
by luteal progesterone.
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CHAPTER 3: EMBRYOS AND ENDOMETRIUM COLLECTED ON DAY 8 OF
INDUCED ALUTEAL CYCLES IN THE MARE EXHIBIT ALTERED GENE
EXPRESSION
3.1 Summary
Aluteal cycles were induced in the mare to evaluate the effects of progesterone
deprivation on the gene expression of embryos and endometrium collected eight days
after ovulation. We hypothesized that the transcript expression would be altered during
induced aluteal cycles (AL) (low progesterone <1 ng/mL) when compared to control
cycles during diestrus (high progesterone; > 4 ng/mL) for 1) the embryonic expression of
progesterone mediated transcripts and those related to normal embryo growth and
development and 2) the endometrial expression of progesterone mediated transcripts and
those related to prostaglandin synthesis and normal pregnancy establishment. Seven
cyclic mares with a median age of 6.5 years (range 3-16) were utilized in a crossover
design. Mares in estrus were artificially inseminated to a fertile stallion and randomly
assigned to control or AL groups. Mares received either saline solution (control mares) or
PGF2α (AL mares), twice daily on days 0, 1, and 2 and once daily on days 3 and 4. Serial
blood samples were collected daily from Day 0 (ovulation) until the day of embryo
collection and endometrial biopsy on Day 8. Mares were monitored until they returned to
estrus and were artificially inseminated. Mares were switched to the opposite treatment
group only after a successful embryo collection occurred during the previous cycle and
only cycles that produced embryos were used for analyses. The study design resulted in
paired samples from each mare for analyses. No significant rise in progesterone was
observed in the AL group with mean concentrations of plasma progesterone remaining <
1.0 ng/mL from ovulation until embryo collection on Day 8. This is in sharp contrast to
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the control (luteal) cycle where a post-ovulatory rise in plasma progesterone was
observed. Real-time RT-PCR was utilized to evaluate the expression of ESR1, PGR,
CYP19A1, P19, SLC35A1, OCD, APOB, AQP3, NEU2 transcripts in the embryos and
PTGS2, P19, ESR1, HK2, sPLA2, PGR, CTGF, IFNE, FGF9, SLC36A2 expression in the
endometrium. Four transcripts showed increased expressed in embryos developed during
AL cycles ESR1, P19, APOB and PGR (p<0.05). Four transcripts showed increased
expressed in endometrium developed during AL cycles sPLA2, PGR, ESR1, FGF9
(p<0.05) and four transcripts showed decreased expression P19, CTGF, IFNE, HK2
(p<0.05). Additionally, staining differences were present in endometrial staining for both
ERα and PR receptor during AL cycles compared to control cycles. Embryos and
endometrium developed in a progesterone-deprived environment during induced aluteal
cycles demonstrated altered transcript expression. These results indicate that adequate
progesterone levels may be a key mediator of the appropriate embryo-maternal
environment during early preimplantation embryo development.
Keywords: equine, PGF2α, embryo, endometrium, progesterone, transcript
3.2 Introduction
A widely accepted principle of mammalian reproduction is that pregnancy cannot
occur without progesterone [3.1]. In the mare, the first one third of gestation relies on
progesterone secreted by the corpora lutea on the equine ovaries [3.1]. After ovulation,
progesterone concentrations rise sharply in the mare and reach peak values of 12-20
ng/mL between Days 5 to 10 after ovulation [3.1]. The primary CL remains the only
source of progesterone for pregnancy support during the first 40 days of gestation, but
plasma concentrations begin to decline around Day 20 [3.1].
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Early embryonic death (EED) occurs in the mare during the first 40 days of
pregnancy [3.2]. This time period is divided into two phases, with the first period defined
as day 0 (fertilization) to 13 and the second period from day 14 to 40 [3.2]. The incidence
of EED during the first period in young fertile mares is reported to be 9% and can be as
high as 73% in older mares or those with decreased fertility [3.2]. One of the factors
involved in early embryonic loss may be hypoleutoidism, insufficiency of the CL, which
results in low levels of progesterone during early pregnancy [3.1, 3.2]. Progesterone is a
key modulator ensuring that the appropriate environment is maintained for establishment
of pregnancy. It ensures uterine quiescence and the production of uterine histotroph, the
primary conceptus nutrition until placentation [3.3-3.7]. It has been described that
embryonic loss is more likely to occur when the circulating progesterone concentration is
< 2 ng/ml compared to increased embryonic survival associated with progesterone
concentrations > 4 ng/ml [3.8].
The preimplantation period is an essential period for the preparation of both the
uterus and embryo for the establishment of pregnancy. Recently, transcriptomic studies
of the equine endometrium have revealed a significant number of genes are differentially
regulated in pregnant vs. nonpregnant mares between days 8 to 13.5 after ovulation [3.9].
Recently, several transcripts have been identified as developmentally important in the
equine blastocyst [3.10]. Furthermore, several genes expressed in the preimplantation
equine conceptus have been found to be upregulated during the course of normal
pregnancy [3.11]. Some of these genes such as apolipoprotein B-100, clone CH241268N6 and Fibrinogen beta chain precursor have been found to increase over 100 fold
from Day 8 to Day 14 in equine conceptuses [3.11]. The preimplantation period marks a
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critical window in which the developing embryo responds to the maternal environment
by permanently modifying its epigenome [3.12]. The time period of early embryogenesis
represents a window where the embryonic genome is exquisitely sensitive to
disadvantageous developmental programming. This period of sensitivity appears to be
concentrated into very early development in mammals, up to the blastocyst stage in mice
and sheep [3.12].
It has recently been demonstrated that the equine preimplantation embryo
expresses membrane bound steroid hormone receptors that exert their effects via nongenomic pathways [2.13]. Furthermore, it was elucidated that the equine embryo
expresses progesterone receptors as early as Day 7 and the level of expression increases
significantly between Days 7 and 10 [13]. Previous work in our laboratory has
demonstrated that progesterone-deprivation during the early preimplantation period can
dramatically affect the morphology of equine embryos collected on Day 8 [2.14].
However, the lasting effects of progesterone-deprivation on these embryos and their
potential for pregnancy establishment have yet to be ascertained. One study evaluated the
developing equine pregnancy during hypoluteal conditions by administration of PGF2α
on either Days 12, 14, 16, or 18 post-ovulation [2.15]. Our laboratory has developed a
novel in vivo model to investigate the effects of progesterone-deprivation during the early
preimplantation period in the mare. In this model serial administration of PGF2α begins
within 12 hours post-ovulation (Day 0), then is administered twice daily on Days 0, 1,
and 2 and then once daily on Days 3 and 4 [2.14, 2.16]. Mares treated according to this
protocol consistently had mean concentrations of plasma progesterone < 1.0 ng/mL
throughout (and after) the study period of Days 0–5 and Days 0-8 post-ovulation [2.14,
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2.16]. The application of this model consisting of 8 serial doses of PGF2α beginning
immediately post-ovulation reliably prevents normal luteal function in the mare [2.14,
2.16].
The present study was developed utilizing our in vivo model to investigate the
effects of progesterone-deprivation on the gene expression of preimplantation embryos
and endometrium recovered from induced aluteal cycles in the mare. We hypothesized
that the transcript expression would be altered during induced aluteal cycles (AL) (low
progesterone <1 ng/mL) when compared to control cycles of normal diestrus (high
progesterone; > 4 ng/mL) for 1) the embryonic expression of progesterone mediated
transcripts as well as those related to normal embryo growth and development and 2) the
endometrial expression of progesterone mediated transcripts as well as those related to
prostaglandin synthesis and normal pregnancy establishment.
3.3 Materials and Methods
3.3.1 Animals and Sample Collection
The Institutional Animal Care and Use Committee of Louisiana State University
School of Veterinary Medicine approved all experimental protocols. The work was
performed in a USDA-registered National Institute of Health-assured, and AAALAC
International accredited animal facility in accordance with The Guide for the Care and
Use of Laboratory Animals [2.17]. Seven cyclic Thoroughbred mares with a median age
of 6.5 years (range 3-16) were utilized in a balanced crossover design from March to
September 2016 in Baton Rouge, LA. Mares were randomly assigned to one of two
treatment groups: control (normal diestrus) or induced aluteal (AL). Mares remained in
the first treatment group assigned to until a positive embryo collection. Immediately after
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the first positive embryo collection, they were assigned to the opposite treatment group
and remained in that treatment group until a positive embryo collection. This study
design resulted in the production of paired samples from control and AL cycles from the
same mare for analyses.
Mares were monitored by transrectal ultrasonography (SonoSite Edge, Fujifilm,
Bothell, WA) throughout the study period. Mares in estrus, as determined by the presence
of uterine edema and a follicle > 35 mm diameter, were treated once with human
chorionic gonadotropin (hCG, 2000 IU, IV, Chorulon, Merck Animal Health,
Kenilworth, NJ). Mares were artificially inseminated every other day until ovulation was
detected with ≥ 1 x 109 total motile spermatozoa from one stallion of known fertility.
Reproductive examinations by ultrasonography were performed twice daily after
insemination until detection of ovulation. After ovulation, mares were randomly assigned
to one of two treatment groups: control (normal diestrus) or induced aluteal (AL). The
AL mares were treated according to a protocol previously described [2.14]. Briefly,
mares were treated twice daily with PGF2α (10 mg, IM, Lutalyse, dinoprost
tromethamine, Zoetis, Florham Park, NJ) on days 0, 1, and 2, and once daily on days 3
and 4 [2.14]. The control group was treated on the same schedule with saline solution (2
mL, IM).
Embryo collections were performed on Day 8 post-ovulation. Embryos were
collected in an aseptic manner using Lactated Ringers Solution (LRS) with no
supplementation (MWI Veterinary Supply, Boise, ID). The uterus was lavaged with 0.5
to 1 L of LRS at a time and an average 4 to 6 L of LRS was used in total. Recovered
embryos were identified using a stereomicroscope (SMZ800, Nikon, Melville, NY).
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Embryos were washed ten times in lactated Ringers solution and immediately
placed into 1.5 mL Eppendorf tubes (Fisher Scientific, Hampton, NH) in minimal media
(2-10 µL) and snap frozen in liquid nitrogen. Samples were stored at -80° C until RNA
isolation was conducted. Immediately after embryo collection, two endometrial biopsies
were taken using alligator-jaw forceps. One biopsy sample was immediately placed in a
1.2 mL cryovial (Nalgene®, VWR, Radnor, PA) and snap frozen in liquid nitrogen.
These samples were stored at -80° C until RNA isolation was conducted. The other
biopsy sample was formalin fixed for a minimum of 24 hours. After being formalin fixed
these samples were embedded in paraffin for histological analysis.
Mares were monitored for a return to estrus by ultrasonography every other day
after embryo collection. When they returned to estrus, mares were artificially inseminated
and managed as described above. Mares remained in the same treatment group until an
embryo was successfully collected. Upon returning to estrus after a successful embryo
collection mares were artificially inseminated and managed as described above and
assigned to the opposite treatment group.
Serial blood samples were collected from Day 0 (ovulation) until 8 days postovulation in both control and AL groups. Ten mL of whole blood was collected in
vacutainer tubes (BD Vacutainer, Becton, Dickinson and Company, Franklin Lakes, NJ)
containing lithium heparin with 20-ga 1-in vacutainer needles. Blood samples were
immediately centrifuged at 3000 x g for 10 minutes. Plasma was harvested and stored at 20° C until assayed for progesterone.
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3.3.2 Progesterone Assay
Concentrations of plasma progesterone were determined by a progesterone
radioimmunoassay (RIA). A technician blinded to treatment protocols and groups
performed the progesterone assays using a MP Biomedical double antibody approach as
previously described [2.18]. Concentrations of plasma progesterone on Days 0 to Day 8
were analyzed by ANOVA for repeated measures (Sigma Plot V14.0, Systat Software,
San Jose, CA). Data are expressed as mean ± SEM and considered significant when P ≤
0.05.
3.3.3 Isolation of RNA
Endometrial tissue homogenization was carried out individually using a Bullet
Blender® Gold (Next Advance, Troy, NY) for 5 min at full speed. To perform
homogenization tissues were placed in 1.5 mL Rino® tubes (RNase free, Next Advance,
Troy, NY) with 8 stainless steel beads (RNase free, SSB14B, Next Advance, Troy, NY)
and 500 µL of lysis buffer to achieve a 2:1:1 ratio of lysis buffer to tissue to beads. Total
cellular RNA was isolated from individual homogenized endometrial samples using the
Pure Link® RNA Mini Kit (12183018A; Thermo Fisher Scientific, Waltham, MA)
according to manufacturer’s instructions. Isolated RNA was quantified via
spectrophotometry using a NanoDrop One™ (Thermo Fisher Scientific, Waltham, MA)
and analyzed for quality by determining RNA integrity number (RIN) using a Fragment
Analyzer™ Automated CE System (Advanced Analytial Technologies, Inc., Ankeny,
IA). Samples with a RIN of ≥ 6.8 were used for analysis and 12 samples had a RIN of >
8.
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Total cellular RNA was isolated from individual Day 8 embryos using the
PicoPure™ RNA Isolation Kit (KIT0202, Thermo Fisher Scientific, Waltham, MA)
according to the manufacturer’s instructions. Isolated RNA was quantified via
spectrophotometry using a NanoDrop One (Thermo Fisher Scientific, Waltham, MA) and
analyzed for quality by determining RNA integrity number (RIN) using a Fragment
Analyzer™ Automated CE System (Advanced Analytical Technologies, Inc., Ankeny,
IA). Samples with a RIN of > 8 were used for analysis.
3.3.4 Real Time RT-PCR
For individual embryo and endometrial samples, cDNA was synthesized using
the SuperScript™ IV VILO™ Master Mix (Thermo Fisher Scientific, Thermo Fisher
Scientific, Waltham, MA). Ten transcripts were chosen for evaluation in the Day 8
endometrium; prostaglandin-endoperoxide synthase 2 [PTGS2], P19 lipocalin [P19],
progesterone receptor [PGR], estrogen receptor [ESR1], hexokinase 2 [HK2],
phospholipase A2 [sPLA2], connective tissue growth factor [CTGF], interferon epsilon
[IFNE], fibroblast growth factor 9 [FGF9], and solute carrier family 36 member A2
[SLC36A2]. Nine transcripts were chosen for evaluation in the Day 8 embryos; ESR1,
PGR, aromatase [CYP19A1], P19, solute carrier family 35 member A1 [SLC35A1],
ornithine decarboxylase 1 [ODC1], apolipoprotein B [APOB], aquaporin 3 [AQP3], and
neuraminidase 2 [NEU2]. These transcripts were selected due to their involvement in
steroidogenesis, embryo growth and development, and the establishment of normal
pregnancy under luteal conditions. Primers were designed using Primer-BLAST
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/), all products were less than 180 bp
and are listed in Table 3.1. Primer specificity was confirmed through sequencing of the
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Table 3.1 List of primers used in real-time RT PCR
Gene name Accession number
GAPDH
NM_001163856.1
FGF9

XM_005601094.2

CTGF

XM_001503316.4

P19

NM_001082509.2

PGR

XM_001498494.4

ESR1

NM_001081772.1

sPLA2

XM_005607005.1

HK2

NM_001081776.1

SLC36A2

XM_005599277.2

IFNE

XM_005605033.2

PTGS2

XM_005609749.1

NEU2

XM_001499122.3

SLC35A1

XM_001500323.4

APOB

XM_014730947.1

AQP3

XM_001917787.4

CYP19A1

NM_001081805.2

ODC1

XM_001502323.5

Sequence 5' --> 3'
F: TTGTCAAGCTCATTTCCTGGTATG
R: GTTAGGGGGTCAAGTTGGGAC
F: GACGTAGCCCGTGCATCTTA
R: TCATCCCATCCGACCGTAGT
F: TGCAGCAGCGTGAAGACATA
R: GTAATGGCAGGCACAGGTCT
F: ATGAAGCACGGGAAGGAGAC
R: ACATCCACATGACATCCGGG
F: GTCAGTGGACAGATGCTGTA
R: CGCCTTGATGAGCTCTCTAA
F: ACGATGCCACCAGACCATTT
R: CATGTGAACCAGCTCCCTGT
F: AGGCAGTCGCTTGGAAGTAT
R: CGGAAATCCAGCAAATGCCC
F: CTCAGAGCGGCTCAAGACAA
R: GCACACCTCCTTGACGATGA
F: GCTTCTGCCACAGGCTTAAC
R: CCGGCTTTGAGTCCATACAT
F: GCACTGGCCATTCTTCATGA
R: CTCCCAAGCATCCAGAGGAA
F: AAAAGATCCTGCCCCATCCG
R: CTCGCTGCAAGTCGTTTGAC
TTTGGCAACTCTGGTGGGAC
GGATTCTGTAGGCATGGGCT
CCGTCGTTAGTGTATGCCGT
CACCTGGTACACTGCTGCAT
GTCTACCAGTGCAACGACCA
TGCCTAAAGCGACCATTCGT
TCGACCAGTTCATTGGCACA
GGGGTTGTTGTAGGGGTCAA
TCCTCCCATCCCATTGTCCA
GTACCCAGATATCGGCCTGG
CATGGGCGCTTATACTGTTG
GAAGTCGTGGTTCTGGATTTG

resulting products. All PCR reactions were carried out in duplicate using Power™
SYBR™ Green Master Mix (Thermo Fisher Scientific, Thermo Fisher Scientific,
Waltham, MA) with a total volume of 10 µl containing 200nM of forward and reverse

42

primer and 1 µl of cDNA. A no-template control and no reverse transcriptase control
(NRT) were included. Resulting Cq values were normalized for the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to obtain ΔCq values. The ΔΔCq
method was used to calculate fold changes between treated and control samples.
Normality of data was confirmed, and ΔCq values were analyzed using a paired t-test
(Sigma Plot V14.0, Systat Software, San Jose, CA). Results were considered significant
when P ≤ 0.05.
3.3.5 Immunohistochemistry
The formalin fixed specimens were processed, embedded and sectioned by
routine histological methods. Sections from each specimen were examined by a board
certified veterinary pathologist to define locations within the endometrium that contained
representative areas of superficial surface epithelium and glands of the stratum
compactum. These areas were marked on each slide. From the corresponding area on the
original blocks, 2 tissue cylinders of 1-mm diameter were cored using a manual tissue
microarrayer. The cores were arranged in the new microarray block at an approximate
distance of 4 mm between each core. The top right corner of each microarray was left
blank to mark the proper orientation.
Tissue Micro Array (TMA) sections were submitted for immunohistochemical
staining for progesterone and estrogen receptor expression. TMA sections were
deparaffinized in xylene and rehydrated in graded alcohol. Antigen retrieval was
performed by incubation in target retrieval solution (DAKO, Santa Clara, CA) at 125°C.
The sections were incubated in 3% hydrogen peroxide in methanol, then blocked in a
serum-free protein block (DAKO, Santa Clara, CA). The sections were then incubated
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with anti-mouse primary antibodies for progesterone and estrogen receptors (PgR ab-8,
prediluted, MS-298-R-7-A and ERα, 1:500 dilution, PA5-16440, ThermoFisher
Scientific, Grand Island, NY). Optimal dilution was determined by titration on whole
sections of equine control endometrial tissue. The sections were incubated with a
biotinylated horse anti-mouse secondary antibody (1:200 dilution) for 30 minutes (Vector
Laboratories, Burlingame, CA). Subsequently, the sections were incubated for 30 minutes
with Vector RTU ABC Elite (Vector Laboratories, Burlingame, CA), followed by
incubation with DAB+ chromogen (DAKO). Each incubation step was followed by rinse
steps in Tris Buffered Saline (TBS) buffer. All sections were counterstained with
hematoxylin.
Each TMA was scanned utilizing the Aperio slide scanning system (Leica
Biosystems, Buffalo Grove, IL) at 40X magnification. Following the scanning procedure,
region selection and staining intensity analysis was performed utilizing Aperio
ImageScope software (Leica Biosystems, Buffalo Grove, IL). The free form pen tool was
used to select three non-continuous areas of luminal endometrial epithelium (LE) and
endometrial glands (GE) in each core. This resulted in 6 total areas of analysis for both
LE and GE for each animal. Image analysis was performed using a Positive Pixel Count
v9.1 algorithm with the following thresholds [Hue Value =.1; Hue Width =.5; Color
Saturation Threshold =0.04; IWP(High) = 220; Iwp(Low)=Ip(High) = 175; Ip(low)
=Isp(High)=100 Isp(Low) =0]. The percent positive pixels in a region was determined by
adding the number of positive pixels (Np) to the number of strong positive pixels (Nsp)
divided by the total number of negative and positive pixels (NTotal). The average
staining intensity was determined by adding the total intensity of positive pixels (Ip) and
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the total intensity of strong positive pixels (Isp) divided by the sum of the number of
positive pixels (Np) and the number of strongly positive pixels (Nsp).
Normality of data was assessed, and percent positive pixels and average staining
intensity were analyzed using a paired t test (Sigma Plot V14.0, Systat Software, San
Jose, CA). Results were considered significant when p ≤ 0.05 and data are expressed as
mean ± SEM.
3.4 Results
3.4.1 Progesterone Assay
The plasma progesterone profiles differed significantly between the control and
AL groups. The mean daily concentration of plasma progesterone remained < 1.0 ng/mL
throughout the study period (Day 0 to 8) in the AL group (Fig. 3.1). This is compared to
the control group where a typical diestrus rise was observed and plasma progesterone
peaked at > 9 ng/mL (Fig. 3.1). A significant difference was observed between the AL
and control group beginning on Day 3 (p < 0.001) (Fig. 3.1). However, it is important to
note that beginning on Day 2 concentrations of plasma progesterone had already risen to
> 2.0 ng/mL in the control group compared to 0.7 ng/mL in the AL group (Fig. 3.1).
3.4.2 Real Time RT-PCR
Evaluation utilizing real-time RT PCR demonstrated altered transcript expression
when Day 8 embryos and endometrium are developed in a progesterone-deprived
environment (< 1.0 ng/mL) during induced aluteal cycles. Eight out of the ten transcripts
evaluated in the endometrium were differentially expressed in AL cycles compared to
controls (Fig. 3.2). Four transcripts showed increased expression in endometrium
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Fig. 3.1. Mean (± S.E.M.) daily concentrations of plasma progesterone in control and
induced aluteal treatment groups. During the induced aluteal cycles the mean daily
concentrations of plasma progesterone remained < 1.0 ng/mL. This is in contrast to the
control (luteal) cycle where a post-ovulatory rise in progesterone was observed. The
mean daily concentrations of plasma progesterone differed significantly in control vs.
aluteal group beginning at Day 3 until the end of the study period (Day 8) (*; p < 0.001)
developed during AL cycles compared to control cycles; sPLA2, PGR, ESR1, FGF9 with

a 3.0, 2.5, 1.2, and 6.3-fold increase, respectively (p < 0.05) (Fig. 3.2). Additionally, P19,
CTGF, IFNE, HK2, showed decreased endometrial expression when developed during
AL cycles with a 0.03, 0.13, 0.12, and 0.14-fold decrease respectively (p < 0.05) (Fig.
3.2). Four genes were significantly upregulated out of the nine genes evaluated in Day 8
AL vs. control embryos (Fig. 3.3). In the Day 8 AL embryos ESR1, P19, APOB, and
PGR exhibited a 1483.9, 93.2, 29.3, and 12.33-fold increase respectively (p < 0.05) (Fig.
3.3).
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Fig. 3.2. Transcript expression in Day 8 control vs. induced aluteal endometrium. Eight
out of ten transcripts evaluated were differentially expressed in the endometrium of
induced aluteal mares vs. control. (*; p < 0.05)
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Fig 3.3. Transcript expression of Day 8 control vs. induced aluteal embryos. Four of the
genes evaluated, ESR1, PGR, P19 and APOB, were significantly upregulated in induced
aluteal embryos vs. control (*; p < 0.05).
3.4.3 Immunohistochemistry
The quantitative evaluation of Day 8 endometrium showed differences in both
ERα and PR staining (Table 3.2). No difference was observed in ERα protein expression
by percent positive pixels or average staining intensity in the LE. Conversely, in the GE,
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a significant difference was observed in the average staining intensity of ERα protein (p <
0.005) (Table 3.2, Fig. 3.4). The average staining intensity of ERα in the control GE was
76.98 ± 2.15 compared to 59.94 ± 2.33 in the AL group (p < 0.005) (Table 3.2, Fig. 3.4).
A significant difference was observed between the control and AL groups in both the
percent positive pixels and average staining intensity of the PR in the LE (p < 0.05)
(Table 3.2, Fig. 3.5). There was an increase in percent positive pixels in AL compared to
control endometrium; 0.422 ± 0.21 vs. 0.234 ± 0.040, respectively (p < 0.05) (Table 3.2,
Fig. 3.5). Additionally, the AL group demonstrated a decrease in average staining
intensity, 63.77 ± 7.44 compared to 73.43 ± 8.68 in the control group (p < 0.05) (Table
3.2, Fig. 3.5). This is compared to the GE where a decrease in the percent positive pixels
of the PR was observed in control vs. AL, 0.425 ± 0.017 vs. 0.634 ± 0.033, respectively
(p < 0.001) (Table 3.2, Fig. 3.5). However, no difference was present in the average
staining intensity of PR in the GE (p > 0.05) (Table 3.2, Fig 3.5).

Table 3.2 Immunohistochemical expression of progesterone receptor (PR) and estrogen
receptor alpha (ERα) in the luminal (LE) and glandular epithelium (GE)
Percent postive pixels
Average staining intensity
Control
AL
Control
AL
PR LE
0.76 ± 0.03
0.75 ± 0.08
89.83 ± 3.72
79.77 ± 4.28
PR GE
0.88 ± 0.02
0.90 ± 0.02
76.98 ± 2.15 a
59.94 ± 2.33 b
ERα LE
0.23 ± 0.02 a
0.42 ± 0.02 b
73.43 ± 8.68 a
63.77 ± 7.44 b
ERα GE
0.43 ± 0.02 a
0.63 ± 0.03 b
57.94 ± 2.90
60.21 ± 1.94
a,b; p < 0.05
3.5 Discussion
The present study utilized induced aluteal cycles in the mare to evaluate the
effects of progesterone-deprivation on the gene expression in Day 8 embryo and
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Al

A2

Fig. 3.4. Sections from Day 8 endometrium stained with anti-mouse primary antibodies
for estrogen receptor alpha. Pairs of the same letter indicate the endometrium was
collected from control and induced aluteal cyles in the same mare. A1) Control cycle;
A2) Induced aluteal cycle. The negative control is inset in each panel.
endometrium. Progesterone-deprived cycles (< 1.0 ng/mL) were induced in all AL mares
throughout the study duration by administration of serial doses of PGF2α beginning
within 12 hours of ovulation. The concentration of progesterone differed significantly
from that of control cycles, which displayed a typical diestrus rise. This altered hormonal
milieu resulted in differential expression of transcripts selected for evaluation in both the
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Al

A2

Fig. 3.5. Sections from Day 8 endometrium stained with anti-mouse primary antibodies
for progesterone receptor. Pairs of the same letter indicate the endometrium was collected
from control and induced aluteal cycles in the same mare. A1) Control cycle; A2)
Induced aluteal cycle. The negative control is inset in each panel.
Day 8 embryo and endometrium. Additionally, the endometrial expression of PR and
ERα protein differed in treatment mares.
Plasma progesterone remained < 1.0 ng/mL throughout the duration of the study
in all treatment mares. A previously validated model utilizing eight serial injections of
PGF2α beginning within 12 hours of ovulation was utilized to induce aluteal cycles in
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treatment mares [3.14, 3.16]. This resulted in a progesterone-deprived in vivo
environment during the early preimplantation period (Days 0 to 8), which was
significantly different than control cycles with elevated plasma progesterone consistent
with diestrus and early pregnancy. Progesterone is essential for appropriate embryo
development during the early preimplantation period in mammals. It has been
demonstrated in the cow and mare that progesterone concentrations are significantly
higher in the oviduct ipsilateral to the ovary with a functioning CL during diestrus and
early pregnancy [3.19, 3.20]. Furthermore, it has been demonstrated both in vitro and in
vivo that the presence of progesterone can have rapid effects on ciliary beat frequency in
the oviducts of humans, mice, cattle, and the guinea pig [3.21-3.24]. The ciliary beat
frequency functions in transport of tubal stage embryos [3.22]. The effects of
progesterone on the oviductal environment and embryo transport is especially important
in the horse where embryo transport through the oviduct lasts 6 days [3.25]. Progesterone
also plays an important role in the preparation of the uterus and endometrium for the
establishment of pregnancy. Endometrial hypertrophy occurs during diestrus and
increases with embryo implantation during pregnancy [3.26, 3.27]. Concurrent with
endometrial hypertrophy, endometrial gland density increases and is directly related to
successful pregnancy outcome in mares [3.28]. These endometrial glands synthesize and
secrete uterine proteins and related substances, which comprise the histotroph, the
primary conceptus nutrition until attachment and placentation [3.29]. The altered
hormonal milieu present in AL cycles likely results in unfavorable effects on both the
embryo and endometrium for the establishment of pregnancy.
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Four transcripts were significantly higher expressed in embryos collected from
AL cycles. These transcripts ESR1, P19, APOB and PGR are related to hormone
signaling, embryonic capsule formation and nutrient transport. The increase in ESR1
transcript, which codes for ERα, is likely due to the lack of progesterone during the AL
cycles. It has been demonstrated that the expression of ERα is increased during estrus and
decreased during pregnancy in the endometrium of mares [3.30]. The hormonal milieu of
AL cycles mimics a mare in estrus with low progesterone versus the progesteronedominated phase of early pregnancy. One of the most abundant proteins of the equine
uterine histotroph is P19, a progesterone mediated lipocalin important in the assembly of
the embryonic capsule [3.31]. One study has elucidated that the expression of P19 is
highest in Day 8 equine conceptus and expression decreases from Day 10 to 14 [3.11]. In
that study, the decreased embryonic P19 transcript expression from Day 10 to 14 was
contributed to the high amounts of P19 supplied to the conceptus of uterine origin [3.11].
The increased expression of P19 in AL embryos may be due the low progesterone
concentrations resulting in a lack of uterine P19 supplied to the conceptus.
Apolipoproteins are proteins that play an essential role in the transport of lipids by
binding lipids to form lipoproteins [3.11]. Embryos recovered from AL cycles are
developmentally delayed compared to Day 8 embryos recovered from a typical diestrus
mare [3.14]. It has been suggested that in the developing equine embryo, similar to the
mouse, APOB may play a role in the transport of lipids via yolk sac mediated synthesis
and secretion of lipoproteins [3.11, 3.32]. This increased expression of APOB may be
attempting to compensate for nutrient deficiencies occurring in a progesterone-deprived
environment. The Day 7 equine embryo expresses mRNA for both genomic and non-

53

genomic progesterone receptors [3.13]. As a result, it has been hypothesized that
reproductive steroids, specifically estrogen and progesterone, may directly affect the
preimplantation equine conceptus and not only act via the endometrium [3.13]. Our
results demonstrating upregulation of PGR transcripts during induced AL cycles supports
this hypothesis.
The expression of eight out of ten endometrial transcripts evaluated was altered in
AL mares. Three of the four transcripts demonstrating an increased expression; sPLA2,
PGR, ESR1, are progesterone mediated [3.30, 3.33, 3.34]. The PLA2 family is the ratelimiting enzyme in the biosynthesis of prostaglandins, and sPLA2 is directly involved in
the synthesis of PGF2α [3.33, 3.35]. A negative correlation exists between PLA2
expression and progesterone levels, which indicates that progesterone controls the
expression levels of the PLA2 family [3.33]. The increased expression of sPLA2 during
AL cycles relates to the negative association of progesterone levels and this transcript.
The ESR1 transcript is a steroid hormone receptor, which codes for ERα protein, and is
involved in uterine development and steroid hormone activity [3.35]. In the mare,
concentrations of ESR1 are highest during estrus and early diestrus, which correspond to
low levels of progesterone as seen in the AL mares [3.34]. The PGR transcript is
progesterone-mediated and constant exposure to progesterone can cause a down
regulation of transcript expression. Expression of PGR is higher during estrus than during
pregnancy in the mare [3.30]. The expression pattern of both ESR1 and PGR in the AL
endometrium parallels the increased expression of these transcripts during estrus with
low progesterone concentrations. It has been postulated that steroid hormones may drive
regulation of the fourth transcript, FGF9. In the mare, the expression of FGF9 is
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upregulated on Day 12 in pregnant endometrium and this increased expression occurs
shortly after the equine embryo begins to secrete significant amounts of estrogens [3.9,
3.36, 3.37]. The expression pattern of FGF9 is complex, and upregulation of this gene
corresponds to estrogen signaling in the pregnant endometrium of the pig, human and
mare [3.9, 3.38-3.40]. This suggests that the expression of FGF9 may also have a
negative correlation with progesterone levels, which may explain the increased
expression of FGF9 in the progesterone-deprived AL cycles.
Four transcripts displayed a decreased expression in the endometrium of AL
mares. The expression of two of these transcripts, HK2 and P19 has been demonstrated to
be progesterone mediated [3.41, 3.32]. Glycogen, the main storage form of glucose in the
body, is a component of the endometrial histotroph and HK2 plays a role in glycogen
synthesis by converting glucose into glucose-6-phosphate [3.41, 3.42]. The transcript
abundance of HK2 is significantly higher during diestrus and pregnancy than during
estrus or anestrus in the mare [3.41]. Thus the expression of HK2 is significantly greater
during the progesterone-dominated phase of the estrous cycle [3.41]. As previously
discussed, P19 is one of the most abundant constituents of equine histotroph and plays a
role in the establishment of the embryonic capsule [3.31]. When evaluating the presence
of immunoreactive P19, it is present in large amounts during diestrus and early pregnancy
and barely detectable in the endometrium of mares in estrus [3.43]. P19 is present in
moderate amounts in the Day 8 conceptus and expression decreases from Day 10 to Day
14 due to the high amounts of uterine P19 supplied to the conceptus [3.11]. The
expression of P19 is progesterone mediated, and the decreased expression of P19 in the
progesterone-deprived cycles of AL mares agrees with previous reports describing a lack
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of P19 expression when progesterone concentrations are low such as during estrus. Type
1 interferons (IFNs) are a family of cytokines with antiviral activity [3.44]. Unlike other
IFNs the expression of IFNE is not regulated by viral infection [3.44]. In humans and
mice, the female reproductive tract constitutively expresses IFNE, and expression is
hormonally driven in both species with highest expression during the estrogen dominated
proliferative phase [3.44, 3.45]. Conversely, the equine endometrium expresses higher
levels of IFNE during the progesterone dominated phases of diestrus and pregnancy
compared to estrus [Klein C., unpublished data]. Furthermore, progesterone receptor
binding sites have been identified in the promotors of both mouse and human IFNE genes
[46]. Due to the unique hormonal regulation of this transcript, it is likely that the
decreased expression of IFNE in the endometrium of AL mares is a result of the
progesterone-deprivation during these cycles. Connective tissue growth factor is a
transcript that has been associated with endometrial cell proliferation, differentiation and
angiogenesis during early pregnancy in the mouse and mare [3.47, 3.48]. One study
demonstrated that CTGF was expressed at high levels in Day 16 pregnant mare
endometrium [3.47]. It is speculated that reciprocal signaling of CTGF and additional
growth factors between the conceptus and endometrium assist in the maintenance of early
pregnancy in the mare [3.47]. It has been described that embryos collected from AL
cycles are developmentally delayed according to diameter, morphology and quality grade
[3.14]. The resulting improperly primed endometrium and developmentally affected
embryos produced during AL cycles likely affected the signaling events required for
appropriate expression of CTGF.
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In the present study, the percent positive pixels of PR in both the LE and GE were
significantly increased in the AL mares. Our findings correspond with reports citing lack
of localization of PR on the LE and GE in pregnant mares [3.49]. During early pregnancy
PR are present at Day 10 and with continuous exposure to progesterone, these receptors
are down regulated [3.49]. Additionally, it has been described that expression level of PR
is greater during estrus than pregnancy in the mare [3.30]. The increase in percent
positive pixels of PR in AL mares likely corresponds to the lack of progesterone resulting
in an environment that mimics estrus. Additionally, this finding correlates with the
increased expression of the PGR transcript in the endometrium of AL mares. The
increased transcript expression likely resulted in an increase in translation and receptor
expression in treated mares. Interestingly, the average staining intensity of PR in the LE
was significantly lower in the AL endometrium. Average staining intensity reflects the
concentration of PR in a given location. This reduced average staining intensity of PR in
AL mares compared to the increased transcript expression of PGR may be due to the
differential localization of PR within the nucleus and cytoplasm in the LE. In the present
study the PR staining was subjectively localized predominantly to the nuclei of the
epithelial cells rather than their cytoplasm. Several reports have described the localization
of PR to the nuclei of the epithelial cells rather than their cytoplasm in the mare [3.30,
3.49]. The only difference noted in the expression of ERα was a decrease in average
staining intensity in AL mares compared to control mares. However, it has previously
been reported that immunolabeling of ERα is more intense during estrus than pregnancy
[3.30]. The present results are the opposite of what would be expected with less intense
ERα staining appearing in the progesterone-deprived endometrium. The decrease in the
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average staining intensity of the ERα may be due to the localization of receptor in the
GE. The localization of the ERα was similar to that of the PR with expression
predominantly localized subjectively to the nuclei versus the cytoplasm. It has previously
been reported that ERα is localized predominantly to the cytoplasm rather than the nuclei
of the epithelial cells in the mare [3.49]. However, the variability in the staining pattern
of ERα seen in this study compared to other studies may be due to differences in the
primary antibody used. Interestingly, the decreased staining intensity of ERα in AL
endometrium conflicts with the increased transcript expression of ESR1 in AL
endometrium. However, transcript expression only partially explains protein expression
and different post-transcriptional regulatory factors regulate mRNA protein expression
[3.30, 3.50]. The analysis of specific distributions of PR and ERα are not within the scope
of this study.
3.6 Conclusions
In the mare adequate progesterone concentrations are essential for the successful
establishment of pregnancy. Hypoluteoidism can result in inadequate progesterone
concentrations incompatible with pregnancy and contribute to EED in the mare. Until
recently, there was no model available to investigate equine pregnancy in hypoluteal
conditions. This study utilized a novel in vivo model to induce aluteal cycles and evaluate
the effects of in vivo progesterone-deprivation on embryos and endometrium. Several of
the transcripts selected for evaluation were differentially expressed in Day 8 embryos and
endometrium collected from AL mares. Additionally, the expression of selected steroid
receptors was altered in the endometrium from AL cycles. The results of this study
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indicate that adequate progesterone levels during the preimplantation period play an
important role in regulating embryonic and endometrial gene expression in the mare.
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CHAPTER 4: PROGESTERONE DEPRIVATION DURING THE
PERIOVULATORY PERIOD CAUSES DELAYED PREGNANCY
DEVELOPMENT IN THE MARE
4.1 Summary
Serial administrations of PGF2α were utilized to induce aluteal cycles in the mare
to evaluate the effects of progesterone-deprivation on embryonic vesicle development in
the mare. We hypothesized that progesterone-deprivation during early embryogenesis
would result in delayed embryonic vesicle size and retarded growth compared to control
cycles. Eight cyclic mares with a median age of 8 years (range 4 to 16) were utilized.
Mares in estrus were artificially inseminated to a fertile stallion and randomly assigned to
control or induced aluteal rescue (ALR) groups. Mares received either saline solution
(control) or PGF2α (ALR), once daily on days 0 through 4. Then on Day 5 post ovulation
mares in the ALR group were administered altrenogest. Serial blood samples were
collected during estrus throughout the duration of the study period. Data are reported as
mean ± S.E.M. The mean daily progesterone concentration from ovulation to altrenogest
administration on Day 5 remained < 1.0 ng/mL in the AL group compared to the control
group where concentrations rose > 2.4 ng/mL on Day 3 and were significantly different
on Days 4 through 11 and Days 14 and 16. Pregnancy rate was significantly different
with 50% in the ALR groups vs. 100% in the control group (p < 0.05). The embryonic
vesicle size was significantly smaller on days 14 and 15 (p < 0.05) of pregnancy in the
ALR compared to the control group. The delayed vesicle size in the ALR group did catch
up to the control group and heartbeats were detected on either Day 22 or 23 in both
groups. This study demonstrated that although embryo development and pregnancy can
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occur in a progesterone-deprived environment normal growth and development may be
altered.
4.2 Introduction
In mammals, progesterone is the solitary hormone required for the establishment
and maintenance of pregnancy [4.1]. Progesterone is responsible for maintaining uterine
quiescence and most importantly for the production of the uterine histotroph [4.2-4.4]. In
the mare, the uterine histotroph contains many progesterone-mediated components such
as P19, a lipocalin essential to the formation of the embryonic capsule [4.5, 4.6]. During
the first 40 days of gestation in the mare a high rate of pregnancy failure can occur [4.1,
4.7]. This time period is divided into two phases, with the first period defined as day 0
(fertilization) to 13 and the second period from day 14 to 40 [4.7]. The incidence of
embryonic loss during the first period in young fertile mares is reported to be 9% and can
be as high as 73% in older mares or those with decreased fertility [4.7]. Early embryonic
loss in the mare has a significant economic impact on the horse industry [4.7]. A variety
of factors contribute to early embryonic loss, and these factors include hypoluteoidism,
resulting in insufficient progesterone concentrations [4.1, 4.7]. Increased embryonic
survival in the mare is associated with progesterone concentrations > 4 ng/ml [4.8].
Progesterone rises sharply after ovulation in the mare [4.9]. Due to this steep rise
almost immediately after ovulation, progesterone is the predominant hormone present
during early embryogenesis. Changes to the embryonic environment that occur within the
first few days of development can have significant effects on subsequent fetal
development [4.10]. The embryonic environment post-ovulation is of particular
importance in the mare due to the extended period of embryo migration from the uterine
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tube to the uterus, which lasts approximately 6 days [4.11]. Furthermore, studies have
shown that the uterine tube ipsilateral to ovulation has elevated concentrations of
progesterone in both the tissue and fluid [4.12]. Additionally, the mare also has a
prolonged period of embryo migration and delayed implantation compared to other
domestic species [4.13]. Appropriate uterine tube environment and proper priming of the
uterus supported by adequate progesterone levels are essential for successful pregnancy
establishment in the mare.
Studies in the mare have evaluated the importance of adequate progesterone
production beginning immediately post-ovulation. Progesterone production from the
newly formed CL beginning as early as 2 days post-ovulation can have a significant
effect on the successful establishment of pregnancy [4.14-4.16]. One study has
demonstrated that equine in vivo embryos produced in a progesterone-deprived
environment are developmentally delayed [4.17]. The embryos produced were subjected
to a continued period of progesterone-deprivation from Day 0 to 8 whereas other studies
have involved only a transient loss of progesterone levels [4.14-4.17].
One question to answer is the viability of embryos subjected to an extended
period of progesterone-deprivation beginning immediately post-ovulation, comparable to
hypoluteoidism, and if these challenged embryos can establish a normal pregnancy. This
study was developed to evaluate the viability of embryos developed during induced
aluteal cycles characterized by plasma progesterone < 1.0 ng/mL in the mare. We
hypothesized that embryos deprived of progesterone during the periovulatory period
(Days 0 to 4) and then “rescued” by administration of altrenogest on Day 5 would be
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developmentally delayed, as indicated by smaller embryonic vesicle diameter and
delayed detection of a heartbeat.
4.3 Materials and Methods
The Institutional Animal Care and Use Committee of Louisiana State University
School of Veterinary Medicine approved all experimental protocols. The work was
performed in a USDA-registered National Institute of Health-assured, and AAALAC
International accredited animal facility in accordance with The Guide for the Care and
Use of Laboratory Animals [4.18]. Eight cyclic light horse mares (4 Quarter Horse, 4
Thoroughbred) with a median age of 8 years (range 4-16) were utilized in a crossover
design during October, 2015, and July to September, 2017, in Baton Rouge, LA.
Mares were monitored by transrectal ultrasonography (SonoSite Edge, Fujifilm,
Bothell, WA) throughout the study period. Mares in estrus as determined by the presence
of uterine edema and with a follicle > 35 mm diameter were treated once with human
chorionic gonadotropin (hCG, 2000 IU, IV, Chorulon, Merck Animal Health,
Kenilworth, NJ). Mares were artificially inseminated every other day until ovulation was
detected with ≥ 1 x 109 total motile spermatozoa from one stallion of known fertility.
Reproductive examinations by ultrasonography were performed twice daily after
insemination until detection of ovulation. After ovulation, mares were randomly assigned
to one of two treatment groups: control (normal diestrus) or induced aluteal rescue
(ALR). The ALR mares were treated according to a protocol previously described [4.19].
Briefly, mares were treated once daily with PGF2α (10 mg, IM, Lutalyse, dinoprost
tromethamine, Zoetis, Florham Park, NJ) on Days 0 through 4 [4.19]. On Day 5 postovulation, mares in the ALR group were administered long acting biorelease altrenogest

67

(225 mg, IM; BET Pharm, Lexington, KY) [4.19]. The control group was treated on the
same schedule with saline solution (2 mL. IM). Mares in both groups were evaluated for
pregnancy by reproductive ultrasonography on Days 12, 13, 14, 15, 17, and 22, or until
Day 14 if not pregnant, and embryonic vesicle diameter was recorded if pregnant.
Serial blood samples were collected from the time mares ovulated (Day 0) until
detection of heartbeat (Days 22 or 23) if pregnant in both control and ALR groups.
Plasma was harvested and stored at -20° C until assayed for progesterone. Concentrations
of plasma progesterone for all cycles resulting in a pregnancy were determined by a
progesterone radioimmunoassay (RIA). For the progesterone RIA, both the intraassay
and interassay coefficients of variants were < 15%. A technician blinded to treatment
protocols and groups performed the progesterone assays using a MP Biomedical double
antibody approach as previously described [4.20].
Normality of data was confirmed and statistical significance for all data analyses
was set at P ≤ 0.05. Data for embryo vesicle diameter and concentrations of plasma
progesterone were analyzed by ANOVA for repeated measures and data for pregnancy
rate was analyzed by a student’s t-test (Sigma Plot V14.0, Systat Software, San Jose,
CA). Data are expressed as mean ± SEM.
4.4 Results
The overall mean progesterone concentration throughout the study duration (Day
0 to Day 23) was significantly different between groups. The ALR group remained < 1.0
ng/mL with an overall concentration of 0.86 ± 0.58 ng/mL compared to the control group
overall concentration of 3.76 ± 0.54 ng/mL (p < 0.001). The mean daily progesterone
concentration from ovulation (Day 0) to altrenogest administration on Day 5 differed
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significantly in the ALR group compared to the control, 0.35 ± 0.16 ng/mL vs. 2.50 ±
0.25 ng/mL respectively (p < 0.001) (Fig. 4.1). The mean concentration of progesterone
in the control group reached 2.43 ng/mL on Day 3 in contrast to a mean concentration of
0.69 ng/mL in the ALR group (Fig 4.1). Concentrations of plasma progesterone differed
significantly between control vs. ALR group beginning on Day 4, remained so until Day
11 and was also significantly different on Days 14 and 16 (p < 0.05) (Fig. 4.1).

Fig. 4.1. Mean (± S.E.M.) daily concentrations of plasma progesterone in control and
induced aluteal rescue treatment groups. During the induced aluteal treatment, note that
serial administration of PGF2α immediately post-ovulation once daily on Days 0 through
4 caused the mean daily concentrations of plasma progesterone to remain < 1.0 ng/mL
from Day 0 through Day 19. This is in contrast to the control (luteal) cycle where
progesterone rose > 2.4 ng/mL on Day 3. The mean daily concentrations of plasma
progesterone differed significantly in control vs. aluteal group beginning on Day 4 and
remained so until Day 11 and also on Days 14 and 16 (*; p < 0.05)
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A significant difference was observed in the pregnancy rate between the ALR
group and the control group; 50% (4/8) compared to 100% (4/4) respectively (p < 0.05).
Overall, the size of the embryonic vesicles in the AL group was smaller than the control
group (Table 14., Fig. 4.2). A significant difference was observed in the size of the
vesicles in the ALR group on Days 14 and 15 (p < 0.05) of pregnancy compared to the
control group (Table 4.1, Fig. 4.2).

Table 4.1 Mean (± S.E.M.) embryonic vesicle diameter on different days post-ovulation
in control and induced aluteal rescue (ALR) treatment groups. The embryonic vesicle
size is smaller on all days examined in ALR vs. control, with a significant difference
observed on Days 14 and 15.
Day of cycle
ALR
Control
(Day 0 = ovulation)
(mm)
(mm)
12
4.55 ± 1.05
8.67 ± 1.33
13
8.03 ± 1.05
12.50 ± 1.04
14
12.01 ± 1.15a
17.75 ± 1.32b
15
16.10 ± 1.23a
22.25 ± 0.63b
17
24.50 ± 1.11
27.25 ± 0.48
a, b; p < 0.05

A heartbeat was detected on either Day 22 or 23 in all pregnancies (control and ALR).
Two of the pregnant mares in the ALR group ovulated a secondary CL during pregnancy.
One mare ovulated the secondary CL at Day 13 and one mare at Day 16.
4.5 Discussion
The present study evaluated the effects of progesterone-deprivation during the
periovulatory period on embryo survival and early pregnancy development in the mare.
Progesterone-deprived (aluteal) cycles defined by mean plasma progesterone < 1.0
ng/mL were induced in all mares subjected to serial PGF2α treatments in the ALR group
from Day 0 until altrenogest administration on Day 5. Delayed embryonic development

70

was noted in the ALR group with overall embryonic vesicle diameter smaller than the
control group on Days 12-15, and 17. The delayed vesicle size in the ALR group did
catch up to the control group and heartbeats were detected on either Day 22 or 23 in both
groups. This study has provided new information about progesterone deprivation during
the early post-ovulatory period and its effects on early pregnancy development in the
mare.

Fig. 4.2. Mean (± S.E.M.) embryonic vesicle diameter in control and induced aluteal
rescue treatment groups. The diameter of the embryonic vesicle is significantly different
in control vs. AL mares on Days 14 and 15. (*; p < 0.05)
Concentrations of plasma progesterone were significantly altered in the ALR
group compared to controls. Serial administration of PGF2α once daily (antiluteogenic
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treatments) altered normal CL development and function. Long acting altrenogest was
administered Day 5 post-ovulation. This synthetic progestagen has a proven bioactivity
for the progesterone receptor in the mare [4.21]. It has been demonstrated that
progesterone is the only hormone required for the maintenance of pregnancy in a variety
of ways. In one study ovariectomized mares remained pregnant after embryo transfer
when supplemented only with progesterone [4.22]. Progesterone is essential for the
production of uterine histotroph, the primary conceptus nutrition until placentation [4.22,
4.23]. Inadequate levels of progesterone are not compatible with pregnancy and increased
embryonic loss is more likely to occur when progesterone is < 2.0 ng/mL [4.8].
A difference was observed in conceptus growth during Days 12-17 when they
were deprived of progesterone during the periovulatory period. These results demonstrate
that the presence of progesterone significantly affects early conceptus development in the
mare. This is in agreement with studies conducted in sheep that found enhanced fetal
growth when progesterone was administered during the first three days of pregnancy
[4.10]. Increased embryo survival and improved development was also seen in cattle
when progesterone was supplemented during the periovulatory period [4.24]. In the
present study pregnancies deprived of progesterone from Day 0 to Day 5 had delayed
development characterized by a smaller vesicle size than control counterparts. One study
demonstrated that the expression of progesterone-mediated endometrial transcripts
related to pregnancy and conceptus nutrition is affected during induced aluteal cycles
[Chapter 3]. The retarded pregnancy during the present study was likely caused by the
altered hormonal milieu present in the AL cycles and the subsequent effects on the
uterine environment.
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The equine conceptus initiates steroidogenesis as early as Day 6 with measurable
amounts of progesterone, androgens, and estrogens isolated from Day 8 embryos [4.25].
At Day 12, significant quantities of estrogens are produced and this continues until Day
20 [4.25, 4.26]. These conceptus-derived estrogens act via endometrial estrogen receptors
and influence uterine function in a way that remains to be elucidated [4.27]. It has been
demonstrated that equine embryos produced in an in vivo progesterone-deprived
environment are developmentally delayed and of lower quality than embryos developed
during normal diestrus with elevated progesterone [4.17]. Additionally, expression of
progesterone-mediated transcripts is altered when in vivo embryos are progesteronedeprived [Chapter 3].
The ALR cycles resulted in a significantly lower pregnancy rate compared to
control cycles. Other studies in the mare have also demonstrated that pregnancy rate is
affected when luteal function is disturbed during the periovulatory period [4.14-4.16].
Although this study was not able to distinguish between fertilization failure and embryo
loss, a fertile stallion, young mares and a crossover design was used. Treatment mares
served as controls and having achieved a 100% pregnancy rate in the control group, it is
our assumption that fertilization failure is not a factor in this study. The results of the
present study concur with similar studies that indicate sufficient concentrations of
progesterone are essential during the periovulatory period to successfully establish
pregnancy [4.14-4.16].
4.6 Conclusions
We have demonstrated that embryo development and pregnancy can occur in a
progesterone-deprived environment. Normal embryonic growth and development were
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altered, but each successful conceptus was able to reach the appropriate parameters by the
time a heartbeat developed. Furthermore, pregnancy rate was significantly affected by
progesterone-deprivation. Future studies to evaluate the effects of periovulatory
progesterone-deprivation on the placentation and epigenetic programming of the fetus are
warranted.
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CHAPTER 5: EVALUATING THE EFFECTS OF AN INDUCED ALUTEAL
CYCLE ON THE FERTILITY OF SUBSEQUENT EMBRYO COLLECTIONS
5.1 Summary
A 3-year-old Thoroughbred mare underwent 3 consecutive embryo collection
cycles to evaluate the effects of an induced aluteal cycle on the fertility of subsequent
embryo collections. In the first cycle (Cycle 1), antiluteogenic treatments were
administered resulting in an aluteal cycle (daily progesterone < 1.0 ng/mL). Embryo
collection was performed 8 days post-ovulation. At the time of embryo collection during
Cycle 1 the mare was in estrus with 2 follicles > 35 mm and the presence of uterine
edema as determined by reproductive ultrasonography. The mare was artificially
inseminated the day of embryo collection and two embryos were successfully collected 8
days post-ovulation (Cycle 2). The mare was monitored for a return to estrus and
artificially inseminated when a follicle ≥ 35 mm was detected. A successful embryo
collection was performed 8 days post-ovulation (Cycle 3). Cycle 2 and 3 were normal
(luteal) cycles demonstrated by a normal post-ovulatory rise in progesterone ranging
from 8 to 30 ng/mL. The interovulatory interval between Cycle 1 and 2 was 10 days
which was significantly different from the interovulatory interval between Cycles 2 and
3, which was 17 days (p < 0.05). This case report describes an embryo collection from a
mare during an aluteal cycle followed by successful consecutive embryo collections
during normal (luteal) cycles. To our knowledge, this is the first report of an embryo
collection from a mare in estrus, followed by a subsequent embryo recovery after
artificial insemination on the same day the previous embryo flush and recovery occurred.
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5.2 Introduction
In the horse, embryo collections are typically performed on Days 7 or 8 after
ovulation, a time when concentrations of blood progesterone are elevated [5.1, 5.2].
Blastocysts or expanded blastocysts are the developmental stages commonly identified in
embryos recovered during that period [5.3]. For mares that are enrolled in programs of
repeated embryo collections, a luteolytic injection of PGF2α is commonly administered
shortly after embryo collection to allow a return to estrus and an opportunity for a new
breeding [5.4]. The time to return to estrus and subsequent ovulation is variable because
mares may be at different stages of follicle development at the time of PGF2α
administration. Ovulation following PGF2α treatment may occur as early as 3 to 5 days
following the luteolytic treatment or take as long as 11-13 days. This variation in
ovulation is due to differences in follicle size when PGF2α is administered. On average,
most mares ovulate 7 to 10 days following PGF2α treatment. Therefore, it is not unusual
for several days to elapse between the day of the embryo flush and the day of the next
breeding.
In the present report, we describe the successful embryo collection from a mare
during an aluteal cycle followed by successful consecutive embryo collections during
normal (luteal) cycles. The mare was in estrus on the day embryo collection was
performed during the aluteal cycle. To our knowledge, this is the first report of an
embryo collection from a mare in estrus, followed by another embryo recovery after
artificial insemination on the same day the previous embryo flush and recovery occurred.
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5.3 Materials and Methods
A 3-year-old Thoroughbred mare underwent 3 consecutive embryo collection
cycles. The mare was monitored by transrectal ultrasonography (SonoSite Edge, Fujifilm,
Bothell, WA). Reproductive ultrasonography was used to identify signs of estrus as
follows: the presence of a follicle ≥ 35 mm diameter, marked endometrial edema and the
absence of luteal tissue. All artificial inseminations were performed with ≥ 1 x 109 total
motile fresh spermatozoa obtained from one stallion of known fertility.
On the first estrus, the mare was artificially inseminated and treated with hCG
(2000 IU, IV, Chorulon, Merck Animal Health, Kenilworth, NJ). The mare was then
examined twice daily to determine the occurrence of ovulation. Once ovulation was
detected (Day 0), the mare was subjected to antiluteogenic treatments (AL) as previously
described [5.5, 5.6]. Briefly, PGF2α (dinoprost tromethamine, 10 mg, IM, Lutalyse,
Zoetis, Florham Park, NJ) was administered twice daily on days 0, 1, and 2 and once
daily on days 3 and 4. Daily blood samples were collected from breeding until the day of
embryo collection on Day 8. Embryo collection was performed in an aseptic manner
using Lactated Ringers Solution (LRS) with no supplementation (MWI Veterinary
Supply, Boise, ID). The uterus was lavaged with 0.5 to 1 L of LRS at a time and a total of
4 L of LRS was used at each embryo collection. Once an embryo was identified it was
classified according to stage of development, photographed and the diameter measured.
A morula 178 µm in diameter was collected on Day 8 post-ovulation from the
first embryo collection. (Fig. 5.1). On the day the morula was collected, the mare was in
estrus as determined by receptivity when teased to a stallion and reproductive
ultrasonography with two preovulatory follicles measuring 41 and 35 mm in diameter,
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and the presence of uterine edema 2 (scale of 0 to 4); the corpus luteum could no longer
be detected. Approximately 2 hours following embryo collection, the mare was
artificially inseminated and administered hCG. Two ovulations were confirmed by
transrectal ultrasonography and another embryo collection was performed on Day 8 post
ovulation resulting in the successful recovery of two expanded blastocysts measuring
1056 and 1031 µm (Fig. 5.1).
Immediately following this second embryo collection, the mare was treated with a
single injection of PGF2α (dinoprost tromethamine,10 mg, IM; Lutalyse, Zoetis, Florham
Park, NJ) and monitored for a return to estrus. Seven days after embryo collection, a 40mm follicle was detected in the presence of uterine edema as detected by reproductive
ultrasonography. On that day, the mare was artificially inseminated and administered
hCG. Ovulation was detected 48 hours post-breeding and a third consecutive embryo
collection was performed on Day 8, resulting in the recovery of an expanded blastocyst
measuring 1510 µm (Fig 5.1).
Plasma samples were analyzed for progesterone concentrations using an
automated fluorometric enzyme immunoassay analyzer (AIA 360®, Tosoh Bioscience,
Inc., South San Francisco, CA), as previously described for horse plasma [5.7].
5.4 Results
The administration of serial PGF2α was successful in inducing an aluteal cycle as
demonstrated by the daily plasma progesterone concentration during the first cycle
remaining < 1.0 ng/mL during the postovulatory period (Fig. 5.2). In contrast, during the
second and third cycle, the mare displayed normal luteal progesterone profiles (Fig. 5.2).
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(b)
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(d)

Fig. 5.1. Embryos collected 8 days post-ovulation from consecutive cycles. During Cycle
1 the embryo collected was classified as a morula and measured 178 µm in diameter (a).
A synchronous double ovulation was detected during Cycle 2 and two expanded
blastocysts measuring 1056 and 1031 µm in diameter were collected (b and c
respectively). An expanded blastocyst 1510 µm in diameter was collected during Cycle 3,
a normal (luteal) cycle (d).
In the present report, a remarkable interval of only 10 days elapsed between the
first two consecutive collections of 8-day old embryos. This was significantly different
than the 17 day interval between the second and third embryo collections (p < 0.05). This
10-day interval was possible because 1) the mare was in estrus on the day the first
embryo collection was performed and she was artificially inseminated two hours after the
successful embryo collection, and 2) she ovulated within 48 hours of hCG administration.
5.5 Discussion
As previously reported, serial administration of PGF2α beginning within 12 hours of
ovulation prevented normal corpus luteum function as confirmed by reproductive
ultrasonography and daily concentrations of plasma progesterone remaining < 1 ng/mL
[5.5, 5.6]. In agreement with our first report describing that early embryonic development
can take place in an aluteal environment, a Day 8 embryo was recovered during an aluteal
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Fig. 5.2. Mean (± S.E.M.) daily concentrations of plasma progesterone (ng/mL). During
cycle 1, the induced aluteal cycle, there was no rise in plasma progesterone with daily
concentrations remaining < 1.0 ng/mL. This is in contrast to cycles 2 and 3, the normal
(luteal) cycles, where a post-ovulatory rise in progesterone was observed. The elevated
plasma progesterone concentration was sustained during the diestrus period until PGF2α
was administered on the day of embryo collection (Day 8).
cycle in the present report [5.5]. The embryo was classified as a morula, denoting marked
delayed development. Its viability could not be ascertained as the aluteal embryo was
processed and frozen for future analysis. In a previous study, 4 mares that were
artificially inseminated and underwent serial PGF2α treatments following ovulation were
treated with injectable altrenogest on Day 6 after ovulation in an attempt to rescue a
potential developing pregnancy [5.8]. Two mares became pregnant and heartbeats were
detected at Day 22 in both pregnancies [5.8]. In the present report, the embryo collected
during the aluteal cycle was developed in a progesterone-deprived environment and the
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mare was already in estrus on the day of embryo collection. It is plausible to speculate
that the viability of that embryo was significantly compromised. Therefore, the viability
of aluteal embryos on Day 8 after ovulation remains to be determined by embryo
collection and transfer to synchronized luteal recipient mares or following rescue by
administration of exogenous progestagens as described in our previous report [5.8].
Equine practitioners have reported the effect of repeated breeding and embryo
flushes on the fertility of embryo donor mares. In one report, 27 embryos were recovered
from 70 embryo flushes, yielding an embryo recovery rate of 38.6% [5.1]. In the
subsequent year, 15 embryos were produced in 21 embryo flushes, resulting in 71%
embryo recovery rate [5.1]. The authors concluded that repeated breeding and embryo
collection attempts did not affect the fertility of embryo donor mares [5.1]. In another
study, 21 mares were subjected to repeat artificial inseminations and embryo flushes
(average of 7 per mare) [5.9]. In this study, the breeding and embryo transfer procedures
were associated with increased chronic inflammation but the future fertility of those
mares was not investigated [5.9]. In the present report, four embryos were recovered
during three consecutive embryo flushes. Three morphologically normal, grade 1
expanded blastocysts were recovered in the two luteal cycles following the first aluteal
cycle. These results are in agreement with our previous reports that showed the potential
for pregnancy or embryo production remains the same for mares ovulating and subjected
to antiluteogenic treatments and for mares artificially inseminated in the post-aluteal
cycle [5.5, 5.6]. Interestingly, as previously reported, the collection of an endometrial
biopsy during estrus does not affect the likelihood of pregnancy [5.10]. In the present
report, two endometrial biopsies were taken immediately after embryo collection and
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approximately 2 hours prior to artificial insemination. Embryos were collected in the
subsequent cycle, illustrating how the collection of an endometrial biopsy during estrus
does not seem to affect the chance for pregnancy in mares artificially inseminated on that
cycle [5.10].
5.6 Conclusions
To our knowledge, this is the first report of an embryo collection from a mare in
estrus, followed by artificial insemination the same day and subsequent embryo
collection occurring 10 days after the previous embryo collection. Further investigation is
warranted to utilize serial treatments of PGF2α applied at different times during the
periovulatory period to shorten the interovulatory interval and embryo collection
efficiency in the mare. Additionally, investigation of the viability of embryos produced in
an aluteal environment can be evaluated utilizing embryo transfer.
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CHAPTER 6: SUMMARIZING DISCUSSION AND CONCLUSIONS
6.1 Discussion
A novel in vivo model was utilized to evaluate the effects of progesterone
deprivation on the Day 8 embryo and endometrium. Additionally, embryos developed in
a progesterone-deprived environment were subsequently rescued by administration of
altrenogest to evaluate the effects of early progesterone deprivation on normal pregnancy
establishment. The administration of serial doses of PGF2α resulted in mean plasma
progesterone < 1.0 ng/mL in all AL groups (Chapters 2-5). This contrasted greatly with
control groups, which displayed a typical diestrus rise up to 10 ng/mL and created a
clearly altered hormonal milieu in control vs. AL groups. The morphological and
molecular characterization of Day 8 embryos in AL vs. control cycles demonstrated that
lack of progesterone adversely affects embryo quality and alters the expression of certain
genes in both the embryos and endometrium (Chapter 2 and 3). The AL cycles
subsequently rescued by altrenogest administration significantly affected pregnancy rate
and normal pregnancy development (Chapter 4). The administration of serial doses of
PGF2α significantly decreased the interovulatory interval (IOI) and had no effect on
future fertility with the successful collection of three embryos from two subsequent
normal diestrus cycles after an AL cycle (Chapter 5).
The model utilized in the present studies is an established model that administers
serial doses of PGF2α within 12 hours of ovulation to prevent normal luteal function
(antiluteogenesis) in the mare [6.1-6.6]. This model reliably results in mean plasma
progesterone < 1.0 ng/mL throughout the duration of the typical diestrus period in the
mare. When the established model administering 8 serial doses of PGF2α was utilized in
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this work, aluteal cycles, as defined by mean plasma progesterone < 1.0 ng/mL, were
induced and maintained in all treated cycles throughout the study period (Day 0 to Day 8)
(Chapters 2-4). When the protocol was modified to administer PGF2α once daily for 4
days beginning within 12 hours of ovulation, aluteal cycles were induced in all treated
mares from Day 0 to the time of altrenogest administration on Day 5 (Chapter 5).
Embryos produced during AL cycles were affected compared to control embryos
produced during normal diestrus (high progesterone) cycles (Chapter 2). It has been
established that the equine embryo expresses non-genomic progesterone receptors as
early as Day 7 [6.7]. The effects of the altered hormonal milieu were detected in the
morphology of the Day 8 AL embryos as well as in the gene expression. The majority of
the Day 8 AL embryos collected were significantly smaller in diameter, earlier in
development, and lower in quality grade. Typically, the stage of embryo recovered at a
Day 8 embryo collection would be an expanded blastocyst visible to the naked eye
measuring between 500-1000 μm [6.8]. The AL embryos were classified as morula and
early blastocysts with diameters between 151-195 μm compared to the expanded
blastocysts between 600-1122 μm in diameter in the control group.
The transcript expression of AL embryos and endometrium was affected (Chapter
3). The AL embryos had a significantly increased expression of four genes ESR1, P19,
APOB and PGR. It has been described that steroid hormones mediate the expression of
ESR1, PGR and P19 [6.7, 6.9, 6.10]. The upregulation of these transcripts is likely due to
the lack of progesterone during AL cycles which mimics estrus vs. diestrus. The
upregulation of APOB, a transcript related to nutrient transport and embryo development,
complements the results of the developmentally delayed and lower quality AL embryos

87

[6.11]. The upregulation of this transcript may be an attempt to increase nutrient uptake
and compensate for nutrient deficiencies experienced during progesterone-deprivation. In
the endometrium four transcripts were upregulated, FGF9, sPLA2, PGR, ESR1, and four
transcripts were downregulated, HK2, P19, IFNE, CTGF. Steroid hormones drive the
expression of sPLA2, PGR, ESR1, HK2, P19, FGF9 and IFNE [6.9, 6.10, 6.12-6.25]. The
altered expression of these transcripts is likely due to the absence of progesterone during
induced aluteal cycles. The remaining transcript, CTGF, is a growth factor implicated in
the maintenance of early pregnancy in the mare [6.26]. It is likely that the endometrial
development in a progesterone-deprived environment during AL cycles negatively
affected the signaling events required for the appropriate expression of CTGF.
It was demonstrated that embryos deprived of progesterone during the early
preimplantation period (Day 0 to Day 4) and rescued by the administration of altrenogest
displayed delayed embryonic vesicle growth overall compared to controls as
characterized by a smaller diameter on Days 12-15 and 17 (Chapter 4). However, the
rescued AL pregnancies were able to establish normal pregnancy parameters as
determined by the detection of a heartbeat at Days 22 or 23. This study is in agreement
with other studies that sufficient concentrations of progesterone are essential during early
the early postovulatory period to establish pregnancy [6.27, 6.28]. The AL cycles also
resulted in a significantly lower pregnancy rate compared to control cycles. Other studies
in the mare have also demonstrated that pregnancy rate is affected when luteal function is
disturbed during the periovulatory period [6.27, 6.28].
It has been demonstrated that the application of antiluteogenic treatments results
in a shortened IOI with no effect on the fertility of subsequent cycles [6.1, 6.6].
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Remarkably, a 10-day interval was recorded between two consecutive embryo collections
after an induced aluteal cycle (Chapter 5). Additionally, the two successful embryo
collections occurred during the cycles immediately following an induced aluteal cycle.
Conflicting reports exist regarding repeated embryo collections in the mare. Some
practitioners report an increase in chronic inflammation and others see no difference on
the fertility of donor mares [6.29, 6.30]. In the present study four embryos were collected
from three consecutive cycles indicating there was no effect on fertility when
antiluteogenic treatments and repeated embryo collections were employed in a young,
fertile mare.
6.2 Conclusions
The present studies characterize the importance of adequate progesterone levels
beginning immediately post-ovulation and continuing throughout the early
preimplantation period and early pregnancy in the mare. The results of this work
demonstrate that progesterone is a key mediator in early embryonic growth and
development. Progesterone plays an important role in the preparation of the endometrium
so pregnancy can be established and maintained. The effects of progesterone on the
preimplantation embryo may be both direct via non-genomic steroid receptors and
indirect via the improperly primed endometrium and inadequate uterine histotroph.
Furthermore, although early pregnancies were affected by progesterone-deprivation, the
administration of an exogenous progestagen rescued the pregnancy and the developing
conceptus was able to reach normal pregnancy parameters up to Day 23. The lasting
effects of progesterone deprivation on the embryo and pregnancy viability have yet to be
determined. Future studies transferring progesterone-deprived embryos to synchronized
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luteal recipients may offer additional information. Additionally, modifications of the
protocol used to induce the aluteal cycles may be applied to shorten the interovulatory
interval and increase reproductive efficiency of embryo donor mares.
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